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ABSTRACT:
Chemical form (i.e., species) can influence metal toxicokinetics and toxicodynamics and
should be considered to improve human health risk assessment. Factors that influence
metal speciation (and examples) include: (1) carrier-mediated processes for specific
metal species (arsenic, chromium, lead, and manganese), (2) valence state (arsenic,
chromium, manganese, and mercury), (3) particle size (lead and manganese), (4) the
nature of metal binding ligands (aluminum, arsenic, chromium, lead and manganese),
(5) whether the metal is an organic versus inorganic species (arsenic, lead and
mercury), and (6) biotransformation of metal species (aluminum, arsenic, chromium,
lead, manganese, and mercury). The influence of speciation on metal toxicokinetics and
toxicodynamics in mammals, and therefore the adverse effects of metals, is reviewed to
illustrate how the physicochemical characteristics of metals and their handling in the
body (toxicokinetics) can influence toxicity (toxicodynamics). Generalizing from mercury,
arsenic, lead, aluminum, chromium, and manganese, it is clear that metal speciation
influences mammalian toxicity. Methods used in aquatic toxicology to predict the
interaction among metal speciation, uptake and toxicity are evaluated. A classification
system is presented to show that the chemical nature of the metal can predict metal ion
toxicokinetics and toxicodynamics. Essential metals, such as iron, are considered.
These metals produce low oral toxicity under most exposure conditions but become
toxic when biological processes that utilize or transport them are overwhelmed, or
bypassed. Risk assessments for essential and nonessential metals should consider
toxicokinetic and toxicodynamic factors in setting exposure standards. Because
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speciation can influence a metal’s fate and toxicity, different exposure standards should
be established for different metal species. Many examples are provided which consider
metal essentiality and toxicity and that illustrate how consideration of metal speciation
can improve the risk assessment process. More examples are available at a website
established as a repository for summaries of the literature on how the speciation of
metals affects their toxicokinetics.
Key words: Metal speciation, risk assessment, toxicodynamics, toxicokinetics

Abbreviations:
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silver

Al

aluminum

Am

americium

As

arsenic

At

astatine

Au
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Ba

barium

Be

beryllium

Bi

bismuth

B

boron

Ca

calcium

Cd

cadmium

Co

cobalt

Cr

chromium
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Cu

copper

Fe

iron

Ga

gallium

Ge

germanium
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gadolinium

Hg

mercury

I

iodine

In
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nickel
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Ti
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INTRODUCTION:
There are important relationships between chemical speciation and toxicity for
many toxic metals. Defining these relationships advances the understanding of
mechanisms and treatments of toxicity and can improve risk assessment. This paper
reviews the impact of speciation on the fate of metals; the interaction of
biotransformation with absorption, distribution and elimination; the impact of speciation
on metal toxicity; and how metal speciation might be incorporated into risk assessment.
The impacts of valence state, isotope, associated ligands and inorganic and organic
species on the fate of metals and their adverse effects are illustrated with many
examples. Metal speciation and associated mechanisms of toxicity in mammals are
reviewed with the objective of determining whether the relationships between speciation
and metal fate and toxicity are empirical, or if models or systems can predict
mammalian toxicity on the basis of chemical properties with the goal of their application
in risk assessment. The companion paper presents the chemical separation and
analytical detection methods most commonly used to speciate metals (Caruso et al.,
2005). It also presents a computational approach to metal speciation based on stability
constants and concentrations of the metal and interacting ligands that can be used with
some metals when physical separation and detection methods are not applicable or
have not been developed.
It is well recognized that a metal’s species can influence its fate in the
environment and in organisms, and therefore its toxicity. However, most regulations in
international legislation concerning trace elements in food, the environment and
occupational settings are based on the total amount of the element rather than
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individual chemical forms (Larsen and Berg, 2001). Chemical speciation is a problem for
the risk assessor because regulations concerning trace element exposure levels usually
ignore the impact of chemical species on bioavailability and toxicity. Elements other
than carbon are typically regulated as classes of compounds containing a named
element rather than specific chemical forms (Duffus, 2001). This review illustrates why
metal speciation matters.

What is Metal Speciation?
There is not a uniformly accepted definition of metal speciation. It has been
suggested that such a definition would reduce confusion (Bernhard et al., 1986;
Swietlik, 1998). A definition developed by the First, Second and Third International
Symposia on Speciation of Elements in Toxicology and Environmental and Biological
Sciences in 1991, 1994 and 1997 states: “Speciation is the occurrence of an element in
separate, identifiable forms (i.e., chemical, physical or morphological state)” (Nieboer et
al., 1999). This definition is not limited to a strict chemical perspective as it recognizes
that compounds of elements can occur in different physical states and that the state can
affect the route and extent of exposure, uptake/absorption and the toxicodynamic
results. The International Union for Pure and Appled Chemistry (IUPAC) developed a
definition in 1997 recommending that speciation “Refers to the chemical form or
compound in which an element occurs in both non-living and living systems. It may also
refer to the quantitative distribution of an element”. In 2000 the IUPAC recommended
definitions that distinguish among the following (Templeton et al., 2000):
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i. Chemical species (of an element): “Specific form of an element defined as to isotopic
composition, electronic or oxidation state, and/or complex or molecular structure”,
ii. Speciation analysis (in chemistry): “Analytical activities of identifying and/or
measuring the quantities of one or more individual chemical species in a sample”,
and
iii. Speciation (in chemistry). “Distribution of an element amongst defined chemical
species in a system.”
Developers of the IUPAC definition suggested that speciation analysis be used when
referring to the analytical activity of identifying and measuring species; that species
transformation1 be used to describe the transformations that take place during cycling of
the elements in geochemical and environmental contexts; and the term speciation be
exclusively reserved to refer to the distribution of species in a particular sample or
matrix (Templeton et al, 2000). These terms have been adopted by IUPAC (Nordberg et
al., 2004) for inclusion in the next edition of the Compendium of Chemical Terminology,
“The Gold book”. A recent review suggests that the IUPAC effort to define speciation,
although admirable, has components that are difficult to understand; raises questions
why the isotopic composition, a nuclear property, is considered a chemical property;
and is narrowly defined, in that distribution is only one of several aspects of speciation,
which should also include the processes of transformation, alteration and interaction
_________________________________________________________________
Footnote1: Because this review focuses on metal speciation in mammals, we discuss
transformation in biological organisms, e.g., biotransformation.
_________________________________________________________________
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among the chemical species. These authors conclude “… speciation study is now just at
the preliminary stage of its developmental process.” (Chai et al., 2004). Although there
has been discussion between those involved in development of the definition that came
out of the International Symposia and by the IUPAC, there are differences among these
definitions. There does not appear to be any planned effort to harmonize these
definitions. The focus of this review is that differences in metals can impact on the
adverse response, and that risk assessment that does not recognize these variables is
an oversimplification and does not take full advantage of current knowledge. As it is well
known that chemical as well as physical properties can impact on the adverse
response, we have considered both in this review.
A variable that contributes to speciation is valence (the combining power of an
atom, determined by the number of electrons in the outer shell of the atom that it will
lose, add or share when reacting with another atom). Many metals have more than one
biologically relevant valence state, discussed below. Another variable contributing to
speciation is the isotope (one of two or more nuclides with the usual number of protons
but differing in mass number due to a different number of neutrons). A third variable is
the associated ligand. A fourth variable is particle size, a form of morphological state. As
it has been repeatedly shown that particle size can influence distribution, especially in
the lung, and the rate of solubility, we have considered particle size as a variable
contributing to metal speciation. Speciation is expected to describe the chemical,
physical and temporal behavior of chemical species in biogeochemical systems (Evans,
2003). In this review we consider how physicochemical variables affect metal
toxicokinetics and the resulting toxicodynamics in mammals.
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The Metals and a New Database on the Impact of Metal Speciation on
Toxicokinetics
Approximately 85% of the elements are metals and/or metalloids (elements that
share properties of both metals and non-metals; B, Si, Ge, As, Sb, Te, Po and At).
Many are essential and/or have considerable toxicity. Although the importance of metal
speciation in toxicokinetics and toxicodynamics is appreciated, metal speciation has not
been determined in most studies (Boisset, 2000). The impact of metal speciation on
metal toxicokinetics and toxicodynamics in aquatic environments has been summarized
and integrated to some extent (Ebdon et al., 2001; Paquin et al., 2002) but a focused
summary of the effects of speciation in mammalian organisms is lacking. A database
has been established to summarize and provide references for the published reports
scattered throughout the periodical literature and in books that describe the impact of
metal speciation on toxicokinetics in mammals
http://www.mc.uky.edu/pharmacy/faculty/yokel/metal-toxicokinetics/. The objectives of
this database are to begin to integrate this literature, illustrate the importance of
speciation on metal toxicokinetics, and advance the refinement of risk assessment of
metals beyond simply consideration of the metal independently of its chemical and
physical form. A sample page from the database is shown in Figure 1.This database
includes metals that are macronutrients (Na, K, Mg and Ca) as well as metals generally
considered to be essential for human health in trace amounts (Cr, Co, Cu, Fe, Mn, Mo,
Se and Zn), metals for which there is circumstantial evidence for essentiality (As, Ni, Si
and V) and metals for which the circumstantial evidence is not as convincing (B, Cd,
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Ge, Pb, Li, Rb, and Sn) (Uthus and Seaborn, 1996; Goyer and Clarkson, 2001). It also
includes metals for which there is considerable toxicity (As, Be, Cd, Cr, Hg, Ni, Po, Ra,
and Pb), intermediate toxicity (Co, Cu, Fe, Mg, Mn, Mo, Se and Zn) and those of lesser
concern (Al, Ag, Am, Au, B, Ba, Bi, Ca, Ga, Ge, In, Li, Po, Pt, Sb, Sn, Sr, Te, Th, Ti, Tl,
U and V) as indicated by the Toxicological Profiles (ATSDR), entries in POISINDEX, the
Handbook on the Toxicology of Metals series (Friberg et al., 1979; Friberg et al., 1986),
Patty’s Toxicology (Bingham et al., 2001) and (Goyer and Clarkson, 2001). It is
apparent that there is considerable overlap between the metals that are essential and
those that are toxic.

Membrane Carriers Affect the Uptake and Toxicity of Many Metals
Many of the essential trace elements, the trace elements that are probably
essential, and the elements that possibly have essential functions produce significant
toxicity (World Health Organization, 1996). It might be anticipated that there are
mechanisms to regulate their fate in mammals to maintain sufficient, as well as nontoxic, concentrations. Membrane transport proteins (carriers or channel molecules in the
plasma cell membrane) have been identified for most of these metals. Plasma
membrane metal transporters may be quite selective, transporting one metal species
but not another, due to selective binding sites that recognize specific chemical species.
Some examples follow. Cr(III) is unable to enter cells but Cr(VI) enters cells through
membrane anion transporters (Singh et al., 1998). Many divalent cations including Cd,
Co, Cu, Fe, Mn, Pb and Zn are substrates for the divalent metal transporter 1 (DMT-1
also known as DCT-1 or nramp-2) which may mediate their intestinal uptake (Gunshin
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et al., 1997; Picard et al., 2000). Transferrin also moves Fe across membranes (Hentze
et al., 2004). It appears that multidrug resistance-associated protein-2 (MRP2) mediates
the biliary transport of glutathione complexes of As and cisplatin and perhaps Cu, Cd and
Hg (Ballatori, 2002). Cu is also transported by a carrier, hCTR2, that is well conserved
across organisms (Zhou and Gitschier, 1997; Lee et al., 2002). Forms of Cr, Mo and Se
are structurally similar to sulfate and can serve as substrates for sulfate transporters
(Ballatori, 2002). Selenomethionine is transported in the intestine by the same transporter
that mediates methionine uptake (Moesgaard and Morrill, 2001). Se(IV) is taken up
erythrocytes by an anion-exchange carrier (Suzuki et al., 1998). In addition to serving as
a substrate for DMT-1, Zn transport is mediated by plasma membrane importers, hZip1,
hZip 2 and ZnT-1 (Ballatori, 2002; Haase and Beyersmann, 2002), members of the
cation diffusion facilitator family (Guffanti et al., 2002) and probably other carriers. A
classic example of carrier-mediated flux is brain uptake by the large neutral amino acid
transporter of the cysteine-methylmercury complex that mimics methionine (Aschner
and Clarkson, 1988). These examples, and others in this review, illustrate that carriers
can influence the fate and toxicity of specific metal species.

Valence State and Isotope can Influence the Fate and Toxicity of Many Metals
Many toxic metals have more than one biologically relevant valence state. These
include: Ag(0, I and II), Am(III, IV, V and VI), As(III and V), Co(II and III), Cr(III and VI),
Cu (0, I and II), Fe(0, II and III), Hg(0, I and II), Mn(II, III and IV), Mo(II, III, IV and VI),
Ni(II and IV), Pu(III, IV, V and VI), Sb(III and V), Se(II, IV and VI), Sn(II and IV), Te(0, II,
IV and VI), Tl(I and III), U(III and VI), V(IV and V), and Zn(0 and II). Biotransformations
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among biologically relevant valence states and estimates of the relative toxicity of the
different valences are shown in the above referenced website. Valence can affect the
absorption, distribution, biotransformation, and elimination of a metal and therefore its
toxicity. For example, Cr(VI) is better absorbed than Cr(III) by the oral and dermal
routes (Mertz, 1969; Langård and Norseth, 1979; Rowbotham et al., 2000).
Comparisons have shown that Sn(II) is better absorbed orally than Sn(IV) (Hiles, 1974),
U(VI) is better absorbed by inhalation than U(IV) (Stokinger, 1981; Eidson, 1994) and
that Se(IV) is better absorbed by inhalation than Se(0) (Medinsky et al., 1981b). Studies
in Caco-2 cells, an in vitro model of the gastrointestinal epithelium, revealed that Fe
treatment decreased cellular uptake of Fe, Mn and Zn, suggesting these metals may
utilize the same cell membrane transporters (Tallkvist et al., 2000). Ingested Fe(II) is
absorbed by enterocytes via DMT-1 (Gunshin et al., 1997). DMT-1 mRNA levels in the
duodenum increase markedly in response to Fe depletion (Gunshin et al., 2001;
Philpott, 2002). It appears that neutral gelatinase-associated lipocalin is another Fe
trafficking protein that transports Fe(III) rather than Fe(II) (Kaplan, 2002). Transferrin in
mammals, and ovotransferrin in birds, also show metal valence selectively, transporting
Fe(III) into cells, via receptor-mediated endocytosis (Evans and Holbrook, 1975). The
valence of a metal can also influence its excretion. As(V) is excreted more rapidly than
As(III) (Hogan and Eagle, 1944). Therefore As(III) is retained to a greater degree than
As(V) (Vahter and Norin, 1980; Lindgren et al., 1982; Vahter and Marafante, 1983). The
relationships between valence state and absorption do not permit one to predict the
relative absorption of two or more metal species based on their relative valences.
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One of the best metals for demonstrating the variation in toxicity resulting from
differing valence states is Hg. Ingested elemental Hg (Hg(0)) is not particularly toxic
because of low gastrointestinal absorption (Bornmann et al., 1970). In contrast, inhaled
Hg(0) is almost completely absorbed by the lungs (Berlin et al., 1969b). Hg(0) is
oxidized to Hg(II) by catalase in erythrocytes (Magos et al., 1978), but not before some
of the lipid-soluble Hg(0) crosses into the CNS (Klaassen, 2001). Absorption of
inorganic Hg(I) and Hg(II) from the gastrointestinal tract is incomplete, but greater than
Hg(0) (Miettinen, 1973; Sin et al., 1983; Yeoh et al., 1986; Sin et al., 1990). The highest
Hg(II) concentrations are found in the proximal renal tubules, the primary site of toxicity
after exposure to inorganic salts and Hg(0) vapor (Goyer and Clarkson, 2001). Inorganic
Hg(I) and Hg(II) do not readily cross the blood-brain barrier whereas Hg(0) and methyl
Hg readily do enter the brain by this route (Berlin et al., 1969a; Suzuki, 1969). Thus the
major symptoms of organic Hg toxicity are neurological, including paresthesias, visual
disturbances and muscle tremors. Neurotoxicity is more prominent with elemental Hg
than with the inorganic forms. Inhalation of Hg vapor is the most common cause of Hginduced acute toxicity, producing chest pain, shortness of breath and renal tubular
necrosis. Chronic exposure to lower levels of Hg vapor produces a toxicity dominated
by neurological signs and vasomotor disturbances, the “mad hatter” signs of increased
excitability, tremors, and gingivitis (Smith, 1992). For Hg it is clear that there are distinct
toxicities associated with each valence state and organic form. For example, Hg(I) is not
as toxic as Hg(II), and until relatively recently was found in some skin creams for its
antiseptic properties (Klaassen, 2001). The order of general toxic potential is: CH3Hg >
Hg(II) > Hg(0) > Hg(I).
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Another metal that exhibits contrasting toxicities as a result of different valence
states is As. There are two primary families of inorganic As compounds – the arsenites
(As(III)) and arsenates (As(V)). As(III) is the principal toxic form and tends to
accumulate in vivo. Mitochondrial respiration mediated by NAD-linked substrates is
inhibited by As(III), due to reaction between the arsenite ion and the dihydrolipoic acid
cofactor required for substrate oxidation (Goyer and Clarkson, 2001). With acute As(III)
overdose the fundamental lesion is endothelial cellular toxicity. Chronic poisoning is
subtle and leads to peripheral distal neuropathy, the most common motor neuropathy.
As(V) competes with phosphate at a co-transporter in renal brush border membranes
and in a transport system in the basolateral border of renal cells. The anion exchange
transport system in erythrocytes also accepts As(V) as a phosphate congener
(Clarkson, 1993).
While there is much physiological conversion of As(V) to As(III), the subsequent
metabolic pathway is more complex than previously conceptualized (Hughes, 2002;
Aposhian et al., 2003). Oxidative methylation ultimately produces monomethylarsonic
acid (MMA(V)) and dimethylarsinic acid (DMA(V)), which are less reactive with tissue
constituents, less acutely toxic, and less cytotoxic than inorganic forms of As. However,
there is evidence that the intermediate metabolites monomethylarsonous acid
(MMA(III)) and dimethylarsinous acid (DMA(III)) are more toxic than As(V), As(III) or the
analogous As(V) metabolites (Cohen et al., 2002; Hughes, 2002).
Therefore, As toxicity is a function of 1) chemical form – the As(V) organic
metabolites are less toxic than the inorganic forms; 2) solubility – As(III) is more soluble
and toxic than As(V); 3) valence state – As(III) is more toxic to the CNS; and 4) duration
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of exposure. At this time the best evidence suggests the order of toxic potential to be:
MMA(III) > DMA(III) > As(III) > As(V) > MMA(V) > DMA(V). Thus, while organification
appears to render metals such as Pb, Hg, and Sn more toxic, no simple generalizations
for metalloids like As are evident.
Examples illustrating the influence of valence on elimination are summarized in
Table 1. These comparisons are from different studies that used different endpoints.
Comparisons should only be made within, not across, studies.
Using Hg and As as examples, it is clear that different valence states exhibit
characteristic patterns of metal toxicity. Could one conclude that valence magnitude
directly correlates with severity of toxicity? The evidence does not generally support
this, as shown in Table 2. While such a relationship may apply for Hg where Hg(II)
produces much more toxicity than Hg(I), this is not true for As(III), Cr(IV) or Cr(V), or
Mn(III). What can be concluded is that severity of toxicity is dependent on how metal
valence states interact with other physiological variables that determine the adverse
response. Given the recognized effects of valence state on toxicokinetics, quality risk
assessment should incorporate valence state-specific differences in toxicity.
Some metals have more than one biologically relevant isotope, including 226Ra
and 228Ra; the anthropogenic 232U and 233U and the natural 234U, 235U and 238U; 238Pu
and 239Pu; and 228Th, 230Th and 232Th. The isotope has been reported to affect
absorption. For example, 238Pu nitrate and dioxide were more rapidly absorbed in the
dog following inhalation exposure than 239Pu nitrate and dioxide, whereas 239Pu nitrate
was absorbed by the rat more rapidly than 238Pu nitrate (Morin et al., 1972; Park et al.,
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1972; Dagle et al., 1983). A simple relationship between the isotope and toxicity is not
evident.

Particle Size can affect Metal Deposition, Uptake and Toxicity
The size of particles affects their deposition in the lung. Pulmonary introduction of
particles > 10 µm diameter results in their deposition into the upper airway and usually
mucociliary clearance into the gastrointestinal tract. Respirable particles ~ 5 µm
diameter enter bronchioles and alveoli. Particles ~ 0.1 µm reach the alveoli, where the
surface area is 100 m2, equivalent to a singles tennis court. Particles can be absorbed
from the bronchioles and alveoli to enter the bloodstream, avoiding first pass hepatic
clearance, as discussed in the Toxicological Profiles on Cd, Mn, Ni, Pb and Tl (ATSDR).
Exposure to equivalent masses of an identically deposited substance may not produce
the same response if particle sizes differ. For instance, ultrafine particles of Ti dioxide
produced a greater inflammatory response in the rat lung than did larger particles
(Oberdörster et al., 1994).

Metal-Associated Ligands and Toxicity
The ligand associated with a metal affects its chemical form, therefore the
speciation of the metal. Ligands are atoms, ions or functional groups that bond to one or
more central atoms or ions, usually metals, to form a complex. For example, the ligand
associated with a metal can affect its solubility which can greatly influence lung
absorption and clearance (Rhoads and Sanders, 1985). The associated ligand can also
affect absorption from other routes as well as the distribution, biotransformation and
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elimination of a metal. These effects on the metal’s fate can influence the adverse
effects produced. For example, the absorption, distribution and subsequent toxicity of
Al, which only exists in biological systems as Al(III), is influenced by its associated
ligand and the stability of the Al-ligand complex. The predominant ligands and their
stability constants have been used to predict the Al species in the calculations
described in (Caruso et al., 2005). Intestinal Al absorption is facilitated by citrate (Goyer
and Clarkson, 2001). In the absence of a complexing ligand such as citrate, hydrolysis
of Al complexes results in sparingly soluble polynuclear species that are less well
absorbed. Over 90% of plasma Al is bound to transferrin; the remainder is bound to low
molecular weight ligands, predominantly citrate (Caruso et al., 2005). Al uptake into the
brain is not well defined. One mechanism may involve transferrin, as occurs with
receptor-mediated endocytosis of Fe(III) (Roskams and Connor, 1990). Citrate is a good
candidate for involvement in brain Al uptake as well (Van Landeghem et al., 1998;
Templeton, 1999). Al efflux from the brain probably does not involve transferrin-receptor
mediated endocytosis as there are thought to be no available transferrin metal binding
sites in brain extracellular fluid to mediate metal efflux by a transferrin-receptor
mediated process (Bradbury, 1997). Al citrate appears to be transported out of the brain
by mechanisms not involving the transferrin receptor (Yokel, 2001).
Solubility can be influenced by the associated ligand. Solubility can affect
absorption. Aqueous solubility enhances absorption from the lung and lipid solubility
enhances dermal absorption. Solubility is a chemical property of metals, therefore a
factor of metal speciation, which can impact on the adverse response of the metal. For
example, following inhalation exposure, soluble forms of a metal enhance systemic
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toxicity whereas respiratory toxicity is more likely from poorly soluble metals
(Schlesinger, 1995). To illustrate, Cd from fumes was absorbed to a greater extent than
Cd carbonate and Cd from pigments (Rusch et al., 1986; Jakubowski, 2001). The oral
bioavailability of soluble Cr(VI) in potassium chromate appears to be higher than Cr(III)
because if Cr(III) is not well complexed it precipitates at physiological pH (Darrie, 2001).
However, the conversion of Cr(VI) by stomach acid to Cr(III) confounds this (Finley et
al., 1997). Also contributing to the superior absorption of Cr(VI) may be its ability to
enter cells by facilitated diffusion mediated by anion exchange and/or sulfate carriers
(Wiegand et al., 1985) whereas Cr(III) cell entry is by passive diffusion and phagocytosis
(Figure 2). The more soluble Cr(VI) salts are also better absorbed through skin than
Cr(III), and presumably also by inhalation (Langård and Norseth, 1979). Greater
absorption of the more soluble chemical forms of many other metals has been reported,
including Ba by inhalation (Einbrodt et al., 1972; Cuddihy et al., 1974) and oral
absorption (Johnson and VanTassell, 1991), Ti by the oral route (Schkroeder et al.,
1963), Mn after its inhalation (Vitarella et al., 2000; Dorman et al., 2001), Co by the oral
route (Barnaby et al., 1968; Hollins and McCullough, 1971; Bailey et al., 1989; AyalaFierro et al., 1999), Ni following inhalation (Benson et al., 1994; Hirano et al., 1994) and
oral exposure (Ishimatsu et al., 1995), Pt by the inhalation route (Moore et al., 1975),
and As after inhalation and oral exposure (ATSDR). Further information and references
to the supporting literature can be found in the web-based database cited above. The
greater absorption of the more soluble forms of many metals is thought to contribute to
greater toxicity. Therefore one mechanism underlying differences in the toxicokinetics of
metal species is their physico-chemical properties.
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Observations concerning metal-associated ligands are largely empirical, so a
question is whether one can identify a model to predict metal ion reactivity and metalligand stability. The importance of the associated ligand is examined in more detail
below with respect to the toxicity of Pb.
Pb is a metal with a single prominent valence state (i.e., II) that avidly forms
complexes in physiological solutions. Some factors that enhance absorption and
distribution have been identified. The major determinant of absorption is the solubility of
the Pb salt, and the process appears to be facilitated diffusion (Goyer and Clarkson,
2001). Transport through an anion exchange channel is a primary means of Pb entry
into cells, and appears to involve a Pb carbonate anion – for example, Pb(CO3)Cl(Simons, 1986). In contrast, Pb(II) transport across the blood-brain barrier has been
hypothesized to be by passive diffusion of PbOH+ (Deane and Bradbury, 1990). Notably,
free hydrated Pb(II) appears to stimulate protein kinase C (Markovac and Goldstein,
1988; Long et al., 1994), to enter neuronal L-type voltage-sensitive Ca(II) channels
(Clarkson, 1993), and may also enter neurons via store-operated Ca(II) channels
(Kerper and Hinkle, 1997). Finally, a significant amount of intracellular Pb(II) is bound to
protein in astrocytes, neurons, renal tubular cells, and erythrocytes.
Another mechanism by which the associated ligand can influence toxicokinetics,
and therefore toxicodynamics, is by influencing the process that moves metals cross
membranes. If the metal-ligand complex is a substrate for carrier-mediated transport,
that process will add to the transmembrane flux provided by diffusion. Among the many
examples of the impact of the associated ligand on the fate of metals is the greater oral
absorption of selenomethionine and selenite than elemental Se, probably due to their
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carrier-mediated uptake (McConnell and Cho, 1965; Anundi et al., 1984). Cd bound to
high molecular weight circulating proteins is mainly trapped by the liver whereas Cd
bound to low molecular weight species, such as metallothionein, distributes into the
kidney and appears in the urine (Jakubowski, 2001). CH3Hg forms a complex with Lcysteine that resembles methionine and is transported into the brain by the L-type
neutral amino acid carrier (Aschner and Clarkson, 1989). Organic forms of As are
excreted more rapidly than inorganic forms (Coulson and al, 1935; Overby and Frost,
1962; Morgareidge, 1963). The several-hundred fold greater concentration of As in bile
than plasma (Klaassen, 1974) may be mediated by multi-drug resistance protein 2
transport of glutathione-As complexes (Ballatori, 2002). The relationship between metalassociated ligands and toxicity has also been examined for Mn(II), and some important
toxicokinetic factors identified. Approximately 87% of plasma Mn(II) is bound to albumin
with most of the balance bound to low-molecular-mass ligands; most Mn(III) is bound to
transferrin (Aschner, 2000). Mn(II) can cross the blood-brain barrier as the citrate, the
free divalent ion, or bound to transferrin (Crossgrove et al., 2003), occurring via
transferrin receptor-mediated endocytosis and other transport processes (Crossgrove
and Yokel, in press). Efflux from the brain appears to occur by simple diffusion (Yokel
et al., 2003). Astrocyte toxicity correlated with the Mn-associated ligand. Solubility of
the Mn(II) salt and intracellular Mn(II) concentration are the major determinants. The
order of toxic potential was MnCl2 > MnSO4 > MnPO4 (Erikson et al., 2002). Mn(II)
accumulation in astrocytes and uptake across the blood-brain barrier appear to occur
via one or more transport processes shared with Ca(II) (Aschner et al., 1992;
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Crossgrove and Yokel, in press). Thus, it is clear that the metal-associated ligand can
profoundly affect bioavailability and the effects of exposure.

Organic Versus Inorganic Metal Species
Comparisons of the relative absorption of inorganic versus organic metal species
generally suggest greater absorption of organic forms. This is illustrated with Hg.
Organic mercurials, such as CH3Hg, are almost completely absorbed from the
gastrointestinal tract and are well absorbed following dermal exposure (Swensson,
1952; Joselow et al., 1972; Nordberg and Skerfving, 1972). These Hg species are
widely distributed throughout the body because of their lipophilic nature (Klaassen,
2001). In contrast, the oral bioavailability of inorganic Hg species is considerably lower
(Sollman and Schreiber, 1936; Rahola et al., 1973). Organotins are often better
absorbed than inorganic Sn species but this varies considerably with the organotin
presumably by all routes of exposure (Heath, 1963; Brüggemann et al., 1964; Bridges et
al., 1967; Mazaev et al., 1976; Winship, 1988). Organolead compounds are better
absorbed by the dermal route than inorganic Pb species (Verity, 1995). Organic Se is
better absorbed orally than inorganic forms (Thomson et al., 1975; Bopp et al., 1982)
(Cummins and Kimura, 1971; Cary et al., 1973; Medinsky et al., 1981a). An exception to
the greater absorption of organic than inorganic species may be As (Bettley and
O'Shea, 1975; Munro, 1976; Crecelius, 1977; Charbonneau et al., 1978; Pomroy et al.,
1980; Vahter and Norin, 1980; Marafante et al., 1981; Tam et al., 1982; Vahter and
Marafante, 1983; Marafante et al., 1984). Another exception is the ability of some amino
acids to decrease oral Co, Cu and Ni absorption (Taylor, 1962; Baker and Czarnecki-
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Maulden, 1987; Johnson and Lee, 1988; Pott et al., 1994; Templeton et al., 2000),
presumably by chelation through formation of a coordination complex. In contrast, some
metals bind to specific amino acids forming species that are substrates for uptake
carriers. For example, this facilitates the oral absorption of Cu (Wapnir and Stiel, 1986)
and distribution to the brain of methylmercury (Aschner and Clarkson, 1988).
Distribution, biotransformation and excretion of organic and inorganic metal forms often
differ as well. The greater toxicity of organic species of several metals, including Pb and
Bi, has been attributed to greater penetration of the blood-brain barrier (Clarkson,
1979). Metallothionein-bound Cd distributed differently than ionic Cd species. The CdMT complex is transported to the kidney, filtered, and reabsorbed into the proximal
tubule via a mechanism involving receptor-mediated endocytosis (Foulkes, 1978;
Squibb et al., 1984; Dudley et al., 1985; Dorian et al., 1992). Some organic Se species
are retained in tissue longer than inorganic species, presumably due to incorporation
into proteins (Sternberg and Imbach, 1967; McConnell and Hoffman, 1972; Hsieh and
Ganther, 1975). This also results in lower rates of organic, than inorganic, Se excretion
(Mangels et al., 1990). Protein-bound metals are not cleared by the kidney as rapidly as
small molecular weight non-protein bound species. The ratio of renal to fecal metal
elimination is also influenced by the species of As. Whereas the ratio is ~ 1 for organic
As, more inorganic As is excreted in feces than in urine (Coulson and al, 1935; Overby
and Frost, 1962; Morgareidge, 1963). Ni carbonyl is excreted by the lungs. After it has
been degraded, the metabolites appear in the urine (Sunderman and Selin, 1968;
Kasprzak and Sunderman, 1969), as also occurs after Ni chloride and sulfite
administration (English et al., 1981; Carvalho and Ziemer, 1982; Medinsky et al., 1987).
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More illustrations of the differences in metal toxicokinetics of organic versus inorganic
metals can be found in the toxicokinetics database mentioned above.

Biotransformation Can Change Metal Fate and Toxicity
Biotransformation can have a profound impact on toxicokinetics and
toxicodynamics. The resultant metal species may have a different ligand and/or valence
state, changing absorption and thereby toxicity. For example, dissolution by gastric
juice has been suggested to increase Ag, Al, B, Ba, Be and Zr solubility and potentially
absorption (Smith and Carson, 1977; Stokinger, 1981; Johnson and VanTassell, 1991;
Reiber et al., 1995) (Culver et al., 2001; Mroz et al., 2001), although Zr and Al have also
been suggested to subsequently become less soluble at the higher pH of the intestine
(Stokinger, 1981; Reiber et al., 1995). In the absence of a complexing ligand such as
citrate, hydrolysis of Al(III) complexes results in sparingly soluble polynuclear species
that result in reduced absorption. Dietary phytates produce insoluble, non-absorbed
complexes with Cu, Fe, Mn and Zn at the gut pH (Windisch, 2002). Phytates similarly
decrease Cr(III) absorption but oxalate enhances it, by preventing formation of insoluble
Cr oxides (Chen et al., 1973).
Biotransformation can also affect metal distribution, elimination and toxicity.
Excellent examples are Hg and As. Hg(0) and organomercurials, such as methyl, ethyl
(in thimerosal, sodium ethylmercurithiosalicylate) and phenyl mercury, can be converted
to inorganic Hg(II) in nearly all organs, including the brain. Redistribution of inorganic
Hg(II) out of the brain and other organs is slow (Magos et al., 1978; WHO, 1990, 1991;
Foulkes, 2001).The prolonged residence time in the brain is thought to contribute to Hg
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toxicity to astrocytes and microglia (Charleston et al., 1996). A substantial portion of
As(V) is rapidly reduced to As(III) in the body in association with thiol oxidation
(Abernathy et al., 1999). As noted in the above discussion on how valence state and
isotope can influence metal fate and toxicity, As(III) is more extensively retained than
As(V). There is also in vivo interconversion of V(IV) and V(V) (Rydzynski, 2001);
oxidation of Mn(II) and Fe(II) to Mn(III) and Fe(III) (Gibbons et al., 1976; Kono et al.,
1976; Ezra et al., 1984; Archibald and Tyree, 1987); and reduction of Cr(VI), and Pt(IV)
to Cr(III), and Pt(II) (De Flora and al, 1986; Petrilli et al., 1986; De Flora and al, 1989;
De Flora et al., 1989; Zhong et al., 1997). Cr(VI), being unstable in vivo, rapidly reduces
to Cr(V) which is labile and coverts to Cr(IV) and ultimately to Cr(III), which is quite
stable due to its complexation with DNA and proteins (Kasprzak, 1991). On the other
hand, there are many metals with completely filled inner electronic orbitals that do not
readily undergo in vivo biotransformation among valence states, such as Al, Pb, Sn, Tl
and Zn.
There are examples where valence changes impact distribution (the rates of cell
entry of V, Fe and Cr and the protein to which Mn binds) (Gibbons et al., 1976;
Danielsson et al., 1982; Langård, 1982; Harris et al., 1984; Templeton et al., 2000) and
elimination (the clearance of Mn and Cr) (Gibbons et al., 1976; Norseth et al., 1982). Be
and Th form insoluble colloids and Gd forms insoluble carbonate and phosphate
precipitates in blood that are then taken up the reticuloendothelial cells (Clarkson, 1979;
Stokinger, 1981; Dean et al., 1988). Ag precipitates and is then transformed into
complexes or elemental metal that accumulates in the skin, producing a blue-gray
discoloration (Danscher, 1981). Cd binds to metallothionein and U binds to bicarbonate
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but the free metals are released in the kidney, producing nephrotoxicity (Bassett et al.,
1948; Cherian and Shaikh, 1975; Squibb and Fowler, 1984). Tetraalkyl tins are
converted to highly toxic trialkyl derivatives (Stoner et al., 1955). Tetraalkyl Pb is
converted to tri-, dialkyl- and to some extent inorganic Pb (Cremer, 1965). Se and Te
are dimethylated, in a detoxification pathway, to species that are exhaled, producing a
characteristic garlic breath (McConnell and Portman, 1952; Taylor, 1996). Organic
species of elements are generally excreted faster than inorganic forms (Apostoli, 1999).
Many more examples illustrating these points are in the above mentioned database.
Biotransformation may be mediated by non-enzymatic as well as enzymatic
processes. For example, Cr(VI) can be reduced non-enzymatically by glutathione to the
more toxic Cr(III) (Kortenkamp et al., 1989). It seems that Cr(VI) can also be reduced
enzymatically by glutathione reductase (Gunaratnam and Grant, 2001).
The rates of non-enzymatic and enzymatic biotransformation processes can
influence whether biotransformation occurs within the residence time of the metal
species in vivo. This is described in (Caruso et al., 2005). For example, the mean
residence time of water in Al(H20)63+ is ~ 1 second, the complexation half-life for
Al(H20)63+ by citrate is ~ 1 to 2 minutes and by fulvic acid 7 to 115 seconds (LopezQuintela et al., 1984; Plankey and Patterson, 1987; Burgess, 1992). The exchange halflife of Al from the Al-fulvic acid complex to an Al-Chelex 100 complex is ~ 4 to 20
minutes at the weaker and ~ 2 to 15 hours at the stronger Al binding site (Sekaly et al.,
1999). The latter exceeds the initial half-life of Al in the mammal (Wilhelm et al., 1990).
Thus, equilibrium among Al species may not occur in vivo before most Al is eliminated.
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Models to Predict Toxicity that Incorporate Speciation
Models have been developed for aquatic toxicology to predict the impact of metal
speciation on the toxic response. The most extensively studied system is the free-ion
activity model (FIAM) which assumes that simple ionic species interact with binding
sites on the cell surface. This model postulates that the biological response elicited by a
dissolved cationic trace metal is a function of the free metal ion concentration (Morel,
1983). The toxic response of aquatic organisms generally relates to the free ion
concentration. Examples of metals that conform to this model include Cd, Cu, Fe, Mn,
Ni, Pb and Zn (Campbell, 1995). There are exceptions. For example, toxicity to green
alga was not proportional to the free Al concentration (Parent et al., 1996). It was
thought that the Al complexing ligand (fulvic acid) interacted with alga to modulate the Al
response. The FIAM is further limited by the observation that the % of free ions in
solution in the environment is generally less than 2% (Donard, 2001) and often cannot
be determined analytically. In seawater most Ni, Mn(II), Zn, Co(II) and Fe(II) are present
as free aquo ions. However, Cd, Cu(I), Ag(I) and Hg(II) complex with chloride (Cl-);
Cu(II) and Pb(II) with carbonate; and Fe(III) and Al with hydroxide ions (Byrne et al.,
1988).
The biotic ligand model (BLM), which also predicts the impact of speciation on
the adverse response, has generated considerable interest for its potential to perform
risk assessment of metals in aquatic environments (see (Paquin et al., 2002) and the 21
companion papers in the same journal issue). This is a chemical equilibrium-based
model founded on the concept that metal binding to defined sites (biotic ligands) at the
point of action, typically the cell surface, is associated with acute toxicity. It recognizes
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that the interaction between the metal’s chemistry and the physiology of the target
organism affects the adverse response, and therefore, risk assessment. It differs from
the FIAM in its emphasis on the biotic ligand, the site of toxicity of the organism. It
assumes that there is competition for binding to the biological ligand among the cationic
metal and dissolved organic matter; inorganic ligands such as hydroxides, chlorides and
carbonates; and competing cations such as Na+, Ca(II), Mg(II) and H+ ions. This model
recognizes that metal speciation affects metal binding to sites of toxicity. Chemical
considerations for the FIAM, BLM and other models are discussed in (Caruso et al.,
2005). Reasonable agreement has been found between experimental toxicity endpoints
and those predicted by the BLM. However, most studies have been conducted using
metal concentrations in excess of those seen in the environment (Batley, 2003). The
BLM has been primarily used to predict toxicity at 96 hours after 3 or 24 hour gill binding
assay exposures because they are more convenient to conduct and provide more
consistent data than longer exposures (Niyogi and Wood, 2003). Application of the BLM
to chronic exposure has been performed (Niyogi and Wood, 2003), and provides
guidance to further development of this model. There is an absence of similar models
that incorporate the many aspects of metal speciation for mammalian organisms.
Although models have been developed for toxicity-inducing metals in mammalian
organisms, they have seldom considered metal speciation. A noteworthy model to
predict metal ion reactivity and metal-ligand stability is the classification system
proposed by Nieboer and colleagues (Nieboer and Richardson, 1980; Nieboer et al.,
1999). This system was developed from fundamental properties of metal ions. It is
based upon electronegativity, the tendency for the metal atom to become negatively
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charged, and coordination number, the number of sites at which complexed ligands
are attached to a metal ion. To classify metal atoms according to their ability to form
covalent bonds the index (χm)2r is utilized, where χm is the electronegativity and r is the
ionic radius of the species with the most common coordination number. This index is
interpreted as comparing valence orbital energy with ionic energy, and thus reflects the
relative ability to form covalent versus ionic bonds. That is, it is a covalent index. A
second index was devised as z2/r to represent ionic interactions, where z is the ion
charge and r is defined as above.
The graph of these two values for ions of 36 metals and two metalloids is shown
in Figure 3. All groups of the periodic chart containing metals are represented, as are all
periods of the chart with the exception of the actinides. With this plot Nieboer and
Richardson (1980) also separated metal and metalloid ions into three groups,
reproducing the traditional groupings of Class A (‘hard’ acids, oxygen donor-atom
seekers), Class B (‘soft’ acids, nitrogen/sulfur donor-atom seekers), and intermediate
metal ions which display ambivalent affinity for donor-atom types (Hancock and Martell,
1996). The purpose of this classification system was to predict metal-ligand stability
and toxicity based on metal ion properties.
For a fixed value of the ionic index in Figure 3, toxicity generally increases with
increasing magnitude of the covalent index. For example, Hg(II) produces more toxicity
than Ca(II). Conversely, for a fixed value of the covalent index, toxicity generally
increases with increasing magnitude of the ionic index. For instance, As(III) produces
more toxicity than Cu(II). In addition, for a fixed value of the covalent index, stability
with nearly all ligands correlates positively with the ionic index. Similarly, for a fixed
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value of the ionic index, stability generally increases with increasing values of the
covalent index. For example, Pb(II) functionally displaces Ca(II) in neurons by impeding
Ca(II) entry through membrane voltage-sensitive channels (Suszkiw et al., 1984) and
exhibiting greater potency to activate Ca(II)-dependent enzymes and proteins (Shao
and Suszkiw, 1991; Long et al., 1994; Kern et al., 2000) Cd(II) has a similar action on
voltage-sensitive Ca(II) channels. Thus, this model suggests that increased metalligand stability results in increased toxicity.
This system is based on general trends in fundamental properties of metal ions,
and has evident limitations. Nonetheless, it is an attempt to bring organization to the
knowledge of metal-ligand associations in order to provide predictive value for toxicity.
Like the FIAM and BLM, it is a laudable step in the right direction. An analogous system
for metal-ligand stability based on ligand (‘hard’/‘soft’ base) properties might also be
useful.
Speciation information has seen only limited application in physiologically-based
models of the kinetics of metals. A model for Cr has parallel absorption and disposition
schemes for Cr(III) and Cr(VI), recognizing the importance of valence on the kinetics
and toxicity of Cr (O'Flaherty, 1996). However, these models have largely ignored
speciation issues and have only addressed 'bulk movement' of metals.
Similarly, although the importance of speciation has been recognized in
epidemiology studies with Al (Gauthier et al., 2000), Hg (Vahter et al., 2000) and Ni
(Teaf et al., 2004), the number of epidemiology studies incorporating speciation as a
variable is quite limited.
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Risk Assessment Considerations for Essential and Toxic Metals
Risk assessment can be defined as a characterization of the potential adverse
health effects of human exposure to environmental hazards. Steps in risk assessment
include a description of potential adverse health effects associated with chemical
exposure, extrapolation of results to estimate the extent of human health effects under
certain conditions of exposure, and uncertainty characterization (Williams and
Paustenbach, 2002). A comprehensive review of regulatory limits set for metals is
beyond the scope of this paper; however, important exposure limits include those set for
occupational (e.g., TLV) or environmental (e.g., Reference Doses (RfDs) and Reference
Concentrations (RfCs)) exposures.
A special challenge for toxicologists is the risk assessment of metals that are
essential and toxic. The dose-response curve for these nutrients is U-shaped where
deficiency or abnormally high exposures can result in adverse effects (Olin, 1998).
Essential metals are obtained from the diet and are often under tight gastrointestinal
and hepatobiliary control. Oral toxicity from most essential metals occurs under high
dose conditions when these normal homeostatic pathways are overwhelmed. For
example, acute Fe poisoning occurs when receptor-dependent processes are saturated
and ingested Fe is passively absorbed down concentration gradients (Mills and Curry,
1994). Poisoning may also result from exposure to a more toxic form of the metal, such
as a more toxic valence state (e.g., Cr(VI) vs. Cr(III)) or a more bioavailable form.
Cr provides a good example to highlight key issues related to risk assessment of
an essential and toxic metal. Cr speciation determines its essentiality and
carcinogenicity (Katz, 1991). It occurs primarily as Cr(III), which is the most stable form,
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as well as Cr(VI). Elemental Cr(0) does not occur naturally. Cr(III) is an essential trace
metal that improves glucose tolerance (Kobla and Volpe, 2000) and is required for the
metabolism of insulin (Katz, 1991; Rowbotham et al., 2000). Cr(III) is typically insoluble
in water, is poorly absorbed from the gastrointestinal tract, and has low oral toxicity.
Cr(III) forms stable complexes with glutathione, ascorbic acid, and other ligands (Yuann
et al., 1999; Gaggelli et al., 2002). Cellular uptake of Cr(III) is low (Figure 2), and it is not
mutagenic (De Flora et al., 1990). Likewise, there is little or no evidence that Cr(III)
compounds are carcinogenic in experimental animals or humans (Katz and Salem,
1993).
In contrast, Cr(VI), including chromate (CrO42-) and dichromate (Cr2O72-) species,
represent anthropogenic forms of Cr. These ions are water soluble and are powerful
oxidizing agents. When ingested, Cr(VI) can be reduced by stomach acids to the less
toxic Cr(III) form (De Flora et al., 1987; Finley et al., 1997). Acidic drinks (e.g.,
lemonade, coffee) can promote Cr(VI) reduction. Reduction of Cr(VI) to Cr(III) is an
important factor when considering the risk associated with Cr ingestion. Indeed, there is
little data to support the notion that ingestion of Cr(VI) is associated with cancer.
Scientific evidence suggests Cr(VI) is not carcinogenic in humans via the oral route at
permissible drinking-water concentrations (Kerger et al., 1996; Proctor et al., 2002;
Paustenbach et al., 2003).
Inhaled particulate forms of Cr(VI) produce respiratory tract toxicity including lung
and nasal cancers. Clinical signs associated with Cr(VI) inhalation include bronchial
asthma, mucosal ulceration, and perforated nasal septum (Feron et al., 2001).
Sinonasal and lung cancers have also been observed in people exposed to relatively
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insoluble forms of Cr(VI) (Feron et al., 2001). Cr(VI) enters cells through membrane
anion (sulfate/phosphate) transporters where it is subsequently reduced to transient
Cr(V) and more stable Cr(III) forms (O'Brien et al., 2003). Cr(III) and Cr(V) can
covalently interact with nucleic acids and other macromolecules (Singh et al., 1998).
Cr(III), Cr(IV), and Cr(V) can react with DNA and induce DNA oxidation and genotoxicity
(O'Brien et al., 2003). Cr provides a clear example where metal speciation must be
accounted for in the risk assessment process.
Toxicity from essential metals can also occur when normal homeostatic control
mechanisms are bypassed. For example, inhalation exposure can result in portal of
entry or systemic effects. Inhalation portal of entry effects relate to nasal or pulmonary
actions. Rhinitis and nasal septum perforations are associated with exposure to Cr(VI)
and As(III) (Sunderman, 2001). Nasal irrigation of Zn sulfate is associated with olfactory
epithelial degeneration, hyposmia, and anosmia (Cancalon, 1982; Sunderman, 2001).
Systemic toxicity can also occur from inhalation exposure. Metal fume fever is a welldocumented acute respiratory disease observed in welders and others who inhale
ultrafine particles of essential and possibly essential metals (e.g., Cu, Mn, Ni, V, or Zn)
as well as nonessential metals (e.g., Al, Be, Cd) (Gordon and Fine, 1993). Systemic
toxicity is not confined to the lung. Inhalation of Fe and Mn provide prime examples
where neurotoxicity can occur.
Toxicity can occur following parenteral injection. For example, individuals
receiving total parenteral nutrition (TPN) were found to be at risk for Mn neurotoxicity.
As with other forms of Mn poisoning, these patients developed elevated serum Mn, they
had symmetrical high intensity magnetic resonance imaging (MRI) lesions in the globus
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pallidus consistent with Mn accumulation at this site, and they developed characteristic
psychiatric symptoms and clinical signs of Mn-induced neurotoxicity (Takagi et al.,
2002). Withdrawal from the TPN supplement significantly decreased blood and brain Mn
levels (Kafritsa et al., 1998; Bertinet et al., 2000). Dermal toxicity can be a concern as
well (Kirchner, 2002). Exposure to essential as well as non-essential metals, such as
Au, Co, Cr and Ni, can produce contact dermatitis.
Recommended Dietary Allowances (RDAs) or Acceptable Daily Intakes (ADIs)
are developed for essential metals. Uncertainty factors used by the nutrition and
toxicology communities to set exposure guidelines for essential metals are not shared.
In particular, toxicity exposure limits (e.g., RfDs) typically rely on animal data and
incorporate uncertainty factors to account for interspecies differences in sensitivity. Most
RDAs are based on human data, thus no additional uncertainty factors are needed to
account for extrapolation of animal data to human risk assessment. The US EPA also
uses a larger uncertainty factor (i.e., up to 10) to describe intraspecies differences than
those used by nutritionists to derive acceptable daily intakes (Mertz, 1995; Olin, 1998).
These disparate approaches can result in overlap between intakes deemed necessary
with those considered potentially toxic (Olin, 1998; Goldhaber, 2003). For example, the
World Health Organization (WHO, 1973) concluded that consumption of 8-9 mg Mn/day
is "perfectly safe” while the current Reference Dose for Chronic Oral Exposure (RfD) is
10 mg Mn/day. The tolerable upper intake level (UL), which is considered the highest
level of daily nutrient intake that is likely to pose no risk of adverse health effects to
almost all individuals in the general population, set for Se and Zn are lower than the
current RfD values for these essential nutrients (Goldhaber, 2003). Most nutritional
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levels do not consider speciation despite the wealth of information indicating that
valence state and ligand binding dramatically alter the bioavailability of essential metals.
Conclusions
In this review the relationships between metal speciation, toxicokinetics and
toxicodynamics have been examined, focusing particular attention on the factors of
valence state, metal-associated ligands and biotransformation. Examples of speciationdependent induced toxicity have been reviewed. An attempt has been made to develop
useful generalizations relative to these factors. Among these generalizations it is
evident that different metal valence states exhibit characteristic patterns of toxicity, and
that the magnitude of the valence state does not correlate with the severity of the
adverse response. Moreover, organic metal species are not always more toxic than
inorganic forms of the same metal. Furthermore, the nature of the metal-associated
ligand can profoundly affect metal ion toxicokinetics and exposure effects. As a result of
this latter observation, a published classification system based on metal properties has
been proposed to have predictive value related to toxicity.
Evaluation of this system indicated that the severity of the adverse response was
generally related to the stability of the metal-ligand complex. Thus, this model might be
utilized to link metal speciation with human health risk assessment. Models have been
developed for aquatic toxicology that focus on the free-ion activity and the interaction
between metal and site of action of toxicity of the organism. Comparable models have
not been developed for mammalian systems.

35

REFERENCES
Abdallah, A., and Saif, M. 1962. Tracer studies with antimony-124 in man. In
Bilharziasis, Ciba Foundation Symposium (G. E. W. Wolstenholme and M.
O'Connor, eds.), pp. 287-309. J. and A. Churchill (London) Little, Brown (Boston),
London.
Abernathy, C. O., Liu, Y. P., Longfellow, D., Aposhian, H. V., Beck, B., Fowler, B.,
Goyer, R., Menzer, R., Rossman, T., Thompson, C., and Waalkes, M. 1999. Arsenic:
health effects, mechanisms of actions, and research issues. Environ. Health
Perspect. 107, 593-597.
Anundi, I., Hogberg, J., and Stahl, A. 1984. Absorption of selenite in the rat small
intestine: interactions with glutathione. Acta Pharmacol. Toxicol. (Copenhagen). 54,
273-277.
Aposhian, H. V., Zakharyan, R. A., Avram, M. D., Kopplin, M. J., and Wollenberg, M. L.
2003. Oxidation and detoxification of trivalent arsenic species. Toxicol. Appl.
Pharmacol. 193, 1-8.
Apostoli, P. 1999. The role of element speciaion in environmental and occupational
medicine. Fresenius J. Anal. Chem. 363, 499-504.
Archibald, F. S., and Tyree, C. 1987. Manganese poisoning and the attack of trivalent
manganese upon catecholamines. Arch. Biochem. Biophys. 256, 638-650.
Aschner, M. 2000. Manganese: brain transport and emerging research needs. Environ.
Health Perspect. 108, 429-432.
Aschner, M., and Clarkson, T. W. 1988. Uptake of methylmercury in the rat brain:
effects of amino acids. Brain Res. 462, 31-39.

36

Aschner, M., and Clarkson, T. W. 1989. Methyl mercury uptake across bovine brain
capillary endothelial cells in vitro: the role of amino acids. Pharmacol. Toxicol. 64,
293-297.
Aschner, M., Gannon, M., and Kimelberg, H. K. 1992. Manganese uptake and efflux in
cultured rat astrocytes. J. Neurochem. 58, 730-735.
ATSDR. Toxicological Profiles. Agency for Toxic Substances and Disease Registry,
Public Health Service, U.S. Department of Health and Human Services. These are
available at: http://www.atsdr.cdc.gov/toxprofiles/tp22.html.
Ayala-Fierro, F., Firriolo, J. M., and Carter, D. E. 1999. Disposition, toxicity, and
intestinal absorption of cobaltous chloride in male Fischer 344 rats. J. Toxicol.
Environ. Health. 56, 571-591.
Bailey, M. R., Kreyling, W. G., Andre, S., Batchelor, A. L., Collier, C. G., Drosselmeyer,
E., Ferron, G. A., Foster, P., Haider, B., Hodgson, A., Masse, R., Metivier, H.,
Morgan, A., Muller, H. L., Patrick, G., Pearman, I., Pickering, S., Ramsden, D.,
Stirling, C., and Talbot, R. J. 1989. An interspecies comparision of the lung
clearance of inhaled monodisperse cobalt oxide. Part 1. Objective and summary
results. J. Aerosol Sci. 20, 169-188.
Baker, D. H., and Czarnecki-Maulden, G. L. 1987. Pharmacologic role of cysteine in
ameliorating or exacerbating mineral toxicities. J. Nutr. 117, 1003-1010.
Ballatori, N. 2002. Transport of toxic metals by molecular mimicry. Environ. Health
Perspect. 110 Suppl 5, 689-694.
Barnaby, C. F., Smith, T., and Thompson, B. D. 1968. Dosimetry of the radioisotopes of
cobalt. Physics Med. Biol. 13, 421-433.

37

Bassett, S. H., Frankel, A., Cedars, N., Van Alstine, H., Waterhouse, C., and Cusson, K.
1948. The excretion of hexavalent uranium following intravenous administration. II.
Studies on human subjects. Univ. of Rochester: U.S. Atomic Energy Commission
Report Report UR-37 (Advisory Committee on human radiation experiments No.
CON-030795-A-1). 54 pages. University of Rochester, Rochester.
Batley, G. 2003. Regulation of toxicants in the Australian environment. Aust. J. Chem.
56, 141-147.
Benson, J. M., Barr, E. B., Bechtold, W. E., Cheng, Y. S., Dunnick, J. K., Eastin, W. E.,
Hobbs, C. H., Kennedy, C. H., and Maples, K. R. 1994. Fate of inhaled nickel oxide
and nickel subsulfide in F344/N rats. Inhal. Toxicol. 6, 167-183.
Berlin, M., Fazackerley, J., and Nordberg, G. 1969a. The uptake of mercury in the
brains of mammals exposed to mercury vapor and to mercuric salts. Arch. Environ.
Health. 18, 719-729.
Berlin, M. H., Nordberg, G. F., and Serenius, F. 1969b. On the site and mechanism of
mercury vapor resorption in the lung. A study in the guinea pig using mercuric nitrate
Hg 203. Arch. Environ. Health. 18, 42-50.
Bernhard, M., Brinckman, F., and Sadler, P. 1986. The importance of chemical
speciation in environmental processes. Springer Verlag, Berlin.
Bertinet, D. B., Tinivella, M., Balzola, F. A., de Francesco, A., Davini, O., Rizzo, L.,
Massarenti, P., Leonardi, M. A., and Balzola, F. 2000. Brain manganese deposition
and blood levels in patients undergoing home parenteral nutrition. J. Parenter.
Enteral. Nutr. 24, 223-227.

38

Bettley, F. R., and O'Shea, J. A. 1975. The absorption of arsenic and its relation to
carcinoma. Br. J. Dermatol. 92, 563-568.
Bingham, E., Cohrssen, B., and Powell, C. H., eds. 2001. Patty's Toxicology. John
Wiley & Sons, Inc., New York.
Boisset, M. 2000. Environmental contamination by trace elements. Consequences for
animal and human health. Comp. Rend. L'Acad. d'Agric. France. 86, 49-65.
Bopp, B. A., Sonders, R. C., and Kesterson, J. W. 1982. Metabolic fate of selected
selenium compounds in laboratory animals and man. Drug Metab. Rev. 13, 271-318.
Bornmann, G., Henke, G., Alfes, H., and Mollmann, H. 1970. Intestinal absorption of
metallic mercury. Arch. Toxikol. 26, 203-209.
Boyd, T. C., and Roy, A. L. 1929. The excretion of antimony in the urine. Indian J. Med.
Res. 17, 94-108.
Bradbury, M. W. 1997. Transport of iron in the blood-brain-cerebrospinal fluid system. J.
Neurochem. 69, 443-454.
Bridges, J. W., Davies, D. S., and Williams, R. T. 1967. Fate of ethyltin and diethyltin
derivatives in the rat. Biochem. J. 105, 1261-1267.
Brüggemann, J., Barth, K., and Niesar, K.-H. 1964. Experimental studies on the content
of triphenylacetate residues in turnip leaves, ensilage of turnip leaves, and in
excrements of animals fed with these products. Zentralbl. Veterinarmed. A. 11, 4-19.
Burgess, J. 1992. Kinetic aspects of chemical speciation. Analyst. 117, 605-611.
Byrne, R. H., Kump, L. R., and Cantrell, K. J. 1988. The influence of temperature and
pH on trace metal speciation in seawater. Mar. Chem. 25, 163-181.

39

Campbell, P. G. C. 1995. Interactions between trace metals and aquatic organisms: A
critique of the free-ion activity model. In Metal Speciation and Bioavailability in
Aquatic Systems (A. Tessier and D. R. Turner, eds.), pp. 45-102. John Wiley & Sons
Ltd, New York.
Cancalon, P. 1982. Degeneration and regeneration of olfactory cells induced by ZnSO4
and other chemicals. Tissue Cell. 14, 717-733.
Caruso, J., Wuilloud, R. G., Wuilloud, J. C. A., and Harris, W. R. 2005. Modeling and
separation-detection methods to evaluate the speciation of metals for toxicity
assessment. J. Toxicol. Environ. Health. this volume.
Carvalho, S. M., and Ziemer, P. L. 1982. Distribution and clearance of 63Ni administered
as 63NiCl2 in the rat: intratracheal study. Arch. Environ. Contam. Toxicol. 11, 245248.
Cary, E. E., Allaway, W. H., and Miller, M. 1973. Utilization of different forms of dietary
selenium. J. Anim. Sci. 36, 285-292.
Chai, Z. F., Zhang, Z. Y., Feng, W. Y., Chen, C. Y., Xu, D. D., and Hou, X. L. 2004.
Study of chemical speciation of trace elements by molecular activation analysis and
other nuclear techniques. J. Anal. At. Spectrom. 19, 26-33.
Charbonneau, S. M., Tam, G. K. H., Bryce, F., and Collins, B. 1978. Pharmacokinetics
and metabolism of inorganic arsenic in the dog. In Proceedings of University of
Missouri's 12th Annual Conference of Trace Substances in Environmental Health,
(D. D. Hemphill, ed.), pp. 276-283, Columbia, Missouri.
Charleston, J. S., Body, R. L., Bolender, R. P., Mottet, N. K., Vahter, M. E., and
Burbacher, T. M. 1996. Changes in the number of astrocytes and microglia in the

40

thalamus of the monkey Macaca fascicularis following long-term subclinical
methylmercury exposure. NeuroToxicology. 17, 127-138.
Chen, J. Y., Tsao, G. C., Zhao, Q., and Zheng, W. 2001. Differential cytotoxicity of
Mn(II) and Mn(III): special reference to mitochondrial [Fe-S] containing enzymes.
Toxicol. Appl. Pharmacol. 175, 160-168.
Chen, N. S., Tsai, A., and Dyer, I. A. 1973. Effect of chelating agents on chromium
absorption in rats. J. Nutr. 103, 1182-1186.
Cherian, M. G., and Shaikh, Z. A. 1975. Metabolism of intravenously injected cadmiumbinding protein. Biochem. Biophys. Res. Commun. 65, 863-869.
Cikrt, M., and Bencko, V. 1974. Fate of arsenic after parenteral administration to rats,
with particular reference to excretion via bile. J. Hyg. Epidemiol. Microbiol. Immunol.
18, 113-120.
Clarkson, T. W. 1979. Effects - General principles underlying the toxic action of metals.
In Handbook on the Toxicology of Metals (L. Friberg, G. F. Nordberg and V. Vouk,
eds.), Vol. 1, pp. 99-117. Elsevier/North-Holland Biomedical Press, Amsterdam.
Clarkson, T. W. 1993. Molecular and ionic mimicry of toxic metals. Annu. Rev.
Pharmacol. 33, 545-571.
Cohen, S. M., Arnold, L. L., Uzvolgyi, E., Cano, M., St John, M., Yamamoto, S., Lu, X.,
and Le, X. C. 2002. Possible role of dimethylarsinous acid in dimethylarsinic acidinduced urothelial toxicity and regeneration in the rat. Chem. Res. Toxicol. 15, 11501157.

41

Coulson, E. J., Remington, R. E., Lynch, K. M. 1935. Metabolism in the rat of the
naturally occurring arsenic of shrimp as compared with arsenic trioxide J. Nutr. 10,
255-270.
Crecelius, E. A. 1977. Changes in the chemical speciation of arsenic following ingestion
by man. Environ. Health Perspect. 19, 147-150.
Cremer, J. E. 1965. Toxicology and biochemistry of alkyl lead compounds. Occup.
Health Rev. 17, 14-19.
Crossgrove, J. S., Allen, D. D., Bukaveckas, B. L., Rhineheimer, S. S., and Yokel, R. A.
2003. Manganese distribution across the blood-brain barrier. I. Evidence for carriermediated influx of managanese citrate as well as manganese and manganese
transferrin. NeuroToxicology. 24, 3-13.
Crossgrove, J. S., and Yokel, R. A. 2005. Manganese distribution across the bloodbrain barrier. IV. Evidence for brain influx through store-operated calcium channels.
NeuroToxicology, in press.
Cuddihy, R. G., Hale, R. P., and Griffith, W. C. 1974. Inhalation exposures to barium
aerosols. Physical, chemical and mathematical analysis. Health Phys. 26, 405-416.
Culver, B., Strong, P., and Murray, J. 2001. Boron. In Patty's Toxicology (E. Bingham,
B. Cohrssen and C. H. Powell, eds.), Vol. 3, pp. 519-582. John WIley & Sons, Inc.,
New York.
Cummins, L. M., and Kimura, E. T. 1971. Safety evaluation of selenium sulfide
antidandruff shampoos. Toxicol. Appl. Pharmacol. 20, 89-96.
Dagle, G. E., Cannon, W. C., Stevens, D. L., and McShane, J. F. 1983. Comparative
disposition of inhaled 238Pu and 239Pu nitrates in beagles. Health Phys. 44, 275-277.

42

Danielsson, B., Hassoun, E., and Dencker, L. 1982. Embryotoxicity of chromium:
distribution in pregnant mice and effects on embryonic cells in vitro. Arch. Toxicol.
51, 233-245.
Danscher, G. 1981. Light and electron microscopic localization of silver in biological
tissue. Histochemistry. 71, 177-186.
Darrie, G. 2001. The importance of chromium in occupational health. In Trace Element
Speciation for Environment, Food and Health (L. Ebdon, L. Pitts, R. Cornelis, H.
Crews, O. F. X. Donard and P. Quevauviller, eds.), pp. 315-330. Royal Society of
Chemistry, Thomas Graham House, Science Park, Milton Road, Cambridge.
De Flora, S., Badolati, G. S., Serra, D., Picciotto, A., Magnolia, M. R., and Savarino, V.
1987. Circadian reduction of chromium in the gastric environment. Mutat. Res. 192,
169-174.
De Flora, S., Bagnasco, M., Serra, D., and Zanacchi, P. 1990. Genotoxicity of chromium
compounds. A review. Mutat. Res. 238, 99-172.
De Flora, S., Serra, D., Camoirano, A., and Zanacchi, P. 1989. Metabolic reduction of
chromium, as related to its carcinogenic properties. Biol. Trace Elem. Res. 21, 179187.
Dean, P. B., Niemi, P., Kivisaari, L., and Kormano, M. 1988. Comparative
pharmacokinetics of gadolinium DTPA and gadolinium chloride. Invest. Radiol. 23
Suppl 1, S258-260.
Deane, R., and Bradbury, M. W. 1990. Transport of lead-203 at the blood-brain barrier
during short cerebrovascular perfusion with saline in the rat. J. Neurochem. 54, 905914.

43

Donard, O. F. X. 2001. Metal speciation for improved environmental management. In
Trace Element Speciation for Environment, Food and Health (L. Ebdon, L. Pitts, R.
Cornelis, H. Crews, O. F. X. Donard and P. Quevauviller, eds.), pp. 115-126. Royal
Society of Chemistry, Thomas Graham House, Science Park, Milton Road,
Cambridge.
Dorian, C., Gattone, V. H., and Klaasen, C. D. 1992. Renal cadmium deposition and
injury as a result of accumulation of cadmium-metallothionein (CdMT) by the
proximal convoluted tubules--A light microscopic autoradiography study with
109CdMT.

Toxicol. Appl. Pharmacol. 114, 173-181.

Dorman, D. C., Struve, M. F., James, R. A., Marshall, M. W., Parkinson, C. U., and
Wong, B. A. 2001. Influence of particle solubility on the delivery of inhaled
manganese to the rat brain: manganese sulfate and manganese tetroxide
pharmacokinetics following repeated (14-day) exposure. Toxicol. Appl. Pharmacol.
170, 79-87.
Dudley, R. E., Gammal, L. M., and Klaassen, C. D. 1985. Cadmium-induced hepatic
and renal injury in chronically exposed rats: likely role of hepatic cadmiummetallothionein in nephrotoxicity. Toxicol. Appl. Pharmacol. 77, 414-426.
Duffus, J. H. 2001. Risk assessment and trace element speciation. In Trace Element
Speciation for Environment, Food and Health (L. Ebdon, L. Pitts, R. Cornelis, H.
Crews, O. F. X. Donard and P. Quevauviller, eds.), pp. 354-372. Royal Society of
Chemistry, Thomas Graham House, Science Park, Milton Road, Cambridge.
Ebdon, L., Pitts, L. H., Cornelis, R., Crews, H., Donard, O. F. X., and Quevauviller, P.,
eds. 2001. Trace Element Speciation for Environment, Food and Health. Royal

44

Society of Chemistry, Thomas Graham House, Science Park, Milton Road,
Cambridge.
Edel, J., Marafante, E., Sabbioni, E., and Manzo, L. 1983. Metabolic behavior of
inorganic forms of antimony in the rat. In 4th International Conference on Heavy
Metals in the Environment, Vol. 1, pp. 574-577. CEP Consultants, Ltd., Edinburgh,
Heidelberg.
Edel, J., and Sabbioni, E. 1988. Retention of intractracheally instilled and ingested
tetrabvalent and pentavalent vanadium in the rat. J. Trace Elem. Electrolytes Health
Dis. 2, 23-30.
Eidson, A. F. 1994. The effect of solubility on inhaled uranium compound clearance: a
review. Health Phys. 67, 1-14.
Einbrodt, H. J., Wobker, F., and Klippel, H. G. 1972. Experimental studies on the
accumulation and distribution of barium sulphate in the rat following inhalation. Int.
Arch. Arbeitsmedizin. 30, 237-244.
English, J. C., Parker, R. D., Sharma, R. P., and Oberg, S. G. 1981. Toxicokinetics of
nickel in rats after intratracheal administration of a soluble and insoluble form. Am.
Ind. Hyg. Assoc. J. 42, 486-492.
Erikson, K. M., Suber, R. L., and Aschner, M. 2002. Glutamate/aspartate transporter
(GLAST), taurine transporter and metallothionein mRNA levels are differentially
altered in astrocytes exposed to manganese chloride, manganese phosphate or
manganese sulfate. NeuroToxicology. 23, 281-288.
Evans, E. 2003. New concepts in speciation analysis. Anal. Bioanal. Chem. 376, 311312.

45

Evans, R. W., and Holbrook, J. J. 1975. Differences in the protein fluorecence of the two
iron(III)-binding sites of ovotransferrin. Biochem. J. 145, 201-207.
Ezra, F. S., Lucas, D. S., and Russell, A. F. 1984. 31P-NMR and ESR studies of the
oxidation states of manganese in Staphylococcus aureus. Biochim. Biophys. Acta.
803, 90-94.
Feron, V. J., Arts, J. H., Kuper, C. F., Slootweg, P. J., and Woutersen, R. A. 2001.
Health risks associated with inhaled nasal toxicants. Crit. Rev. Toxicol. 31, 313-347.
Finley, B. L., Kerger, B. D., Katona, M. W., Gargas, M. L., Corbett, G. C., and
Paustenbach, D. J. 1997. Human ingestion of chromium (VI) in drinking water:
pharmacokinetics following repeated exposure. Toxicol. Appl. Pharmacol. 142, 151159.
Foulkes, E. 2001. Mercury. In Patty's Toxicology (E. Bingham, B. Cohrssen and C.
Powell, eds.), Vol. 2, pp. 327-352. John Wiley and Sons, Inc., New York.
Foulkes, E. C. 1978. Renal tubular transport of cadmium-metallothionein. Toxicol. Appl.
Pharmacol. 45, 505-512.
Friberg, L., Nordberg, G. F., and Vouk, V. B., eds. 1986. Handbook on the Toxicology of
Metals. Elsevier, Amsterdam.
Friberg, L., Nordberg, G. F., and Vouk, V. B., eds. 1979. Handbook on the Toxicology of
Metals. Elsevier/North-Holland Biomedical Press, Amsterdam.
Gaggelli, E., Berti, F., D'Amelio, N., Gaggelli, N., Valensin, G., Bovalini, L., Paffetti, A.,
and Trabalzini, L. 2002. Metabolic pathways of carcinogenic chromium. Environ.
Health. Perspect. 110 Suppl 5, 733-738.

46

Gauthier, E., Fortier, I., Courchesne, F., Pepin, P., Mortimer, J., and Gauvreau, D. 2000.
Aluminum forms in drinking water and risk of Alzheimer's disease. Environ. Res. 84,
234-246.
Gellhorn, A., Tupikova, N. A., and Van Dyke, H. B. 1946. The tissue-distribution and
excretion of four organic antimonials after single or repeated administration to
normal hamsters. J. Pharmacol. Exp. Ther. 87, 169-180.
Gibbons, R. A., Dixon, S. N., Hallis, K., Russell, A. M., Sansom, B. F., and Symonds, H.
W. 1976. Manganese metabolism in cows and goats. Biochim. Biophys. Acta. 444,
1-10.
Goldhaber, S. B. 2003. Trace element risk assessment: essentiality vs. toxicity. Regul.
Toxicol. Pharmacol. 38, 232-242.
Goodwin, L. G., and Page, J. E. 1943. A study of the excretion of organic antimony
using a polarographic procedure. Biochem. J. 37, 198-209.
Gordon, T., and Fine, J. M. 1993. Metal fume fever. Occup. Med. 8, 504-517.
Goyer, R. A., and Clarkson, T. W. 2001. Toxic effects of metals. In Casarett and Doull's
Toxicology - The Basic Science of Poisons (C. D. Klaassen, ed.), pp. 811-867.
McGraw-Hill, New York.
Guffanti, A. A., Wei, Y., Rood, S. V., and Krulwich, T. A. 2002. An antiport mechanism
for a member of the cation diffusion facilitator family: divalent cations efflux in
exchange for K+ and H+. Mol. Microbiol. 45, 145-153.
Gunaratnam, M., and Grant, M. H. 2001. The role of glutathione reductase in the
cytotoxicity of chromium (VI) in isolated rat hepatocytes. Chem. Biol. Interact. 134,
191-202.

47

Gunshin, H., Allerson, C. R., Polycarpou-Schwarz, M., Rofts, A., Rogers, J. T., Kishi, F.,
Hentze, M. W., Rouault, T. A., Andrews, N. C., and Hediger, M. A. 2001. Irondependent regulation of the divalent metal ion transporter. FEBS Lett. 509, 309-316.
Gunshin, H., Mackenzie, B., Berger, U. V., Gunshin, Y., Romero, M. F., Boron, W. F.,
Nussberger, S., Gollan, J. L., and Hediger, M. A. 1997. Cloning and characterization
of a mammalian proton-coupled metal-ion transporter. Nature. 388, 482-488.
Haase, H., and Beyersmann, D. 2002. Intracellular zinc distribution and transport in C6
rat glioma cells. Biochem. Biophys. Res. Commun. 296, 923-928.
Hamel, F., and Duckworth, W. 1995. The realtionship between insulin and vanadium
metabolism in insulin target tissues. Mol. Cell. Biochem. 153, 95-102.
Hancock, R. D., and Martell, A. E. 1996. Hard and soft acid-base behavior in aqueous
solution. J. Chem. Educ. 73, 654-661.
Harris, W. R., Friedman, S. B., and Silberman, D. 1984. Behavior of vanadate and
vanadyl ion in canine blood. J. Inorg. Biochem. 20, 157-69.
Heath, D. F. 1963. Some problems in the determination of residues in plants and
mammals. In Radiation and radioisotopes applied to insects of agricultural
importance. Proceedings of the Symposium on the Use and Application of
Radioisotopes and Radiation in the Control of Plant and Animal Insect Pests., pp.
185-193. International Atomic Energy Agency, Vienna.
Hentze, M. W., Muckenthaler, M. U., and Andrews, N. C. 2004. Balancing acts:
molecular control of mammalian iron metabolism. Cell. 117, 285-297.
Hiles, R. A. 1974. Absorption, distribution and excretion of inorganic tin in rats. Toxicol.
Appl. Pharmacol. 27, 366-379.

48

Hirano, S., Shimada, T., Osugi, J., Kodama, N., and Suzuki, K. T. 1994. Pulmonary
clearance and inflammatory potency of intratracheally instilled or acutely inhaled
nickel sulfate in rats. Arch. Toxicol. 68, 548-554.
Hogan, R. B., and Eagle, H. 1944. The pharmacologic basis for the widely varying
toxicity of arsenicals. J. Pharmacol. Exp. Ther. 80, 93-113.
Hollins, J. G., and McCullough, R. S. 1971. Radiation dosimetry of internal
contamination by inorganic compounds of cobalt: an analysis of cobalt metabolism in
rats. Health Phys. 21, 233-246.
Hsieh, H. S., and Ganther, H. E. 1975. Acid-volatile selenium formation catalyzed by
glutathione reductase. Biochemistry. 14, 1632-1636.
Hughes, M. 2002. Arsenic toxicity and potential mechanisms of action. Toxicol. Lett.
133, 1-16.
Ishimatsu, S., Kawamoto, T., Matsuno, K., and Kodama, Y. 1995. Distribution of various
nickel compounds in rat organs after oral administration. Biol. Trace Elem. Res. 49,
43-52.
Jakubowski, M. 2001. Zinc and cadmium. In Patty's Toxicology (E. Bingham, B.
Cohrssen and C. Powell, eds.), Vol. 2, pp. 253-325. John Wiley and Sons, Inc., New
York.
Johnson, C. H., and VanTassell, V. J. 1991. Acute barium poisoning with respiratory
failure and rhabdomyolysis. Ann. Emerg. Med. 20, 1138-1142.
Johnson, P. W., and Lee, D.-Y. 1988. Copper absorption and excretion measured by
two methods in rats fed varying concentrations of dietary copper. J. Trace Elem.
Exp. Med.. 1, 129-141.

49

Joselow, M. M., Louria, D. B., and Browder, A. A. 1972. Mercurialism: environmental
and occupational aspects. Ann. Intern. Med. 76, 119-130.
Kafritsa, Y., Fell, J., Long, S., Bynevelt, M., Taylor, W., and Milla, P. 1998. Long-term
outcome of brain manganese deposition in patients on home parenteral nutrition.
Arch. Dis. Child. 79, 263-265.
Kaplan, J. 2002. Mechanisms of cellular iron acquisition: another iron in the fire. Cell.
111, 603-606.
Kasprzak, K. S. 1991. The role of oxidative damage in metal carcinogenicity. Chem.
Res. Toxicol. 4, 604-615.
Kasprzak, K. S., and Sunderman, F. W., Jr. 1969. The metabolism of nickel carbonyl14C.

Toxicol. Appl. Pharmacol. 15, 295-303.

Katz, S. A. 1991. The analytical biochemistry of chromium. Environ. Health Perspect.
92, 13-16.
Katz, S. A., and Salem, H. 1993. The toxicology of chromium with respect to its
chemical speciation: a review. J. Appl. Toxicol. 13, 217-224.
Kerger, B. D., Richter, R. O., Chute, S. M., Dodge, D. G., Overman, S. K., Liang, J.,
Finley, B. L., and Paustenbach, D. J. 1996. Refined exposure assessment for
ingestion of tapwater contaminated with hexavalent chromium: consideration of
exogenous and endogenous reducing agents. J. Exp. Anal. Environ. Epidemiol. 6,
163-179.
Kern, M., Wisniewski, M., Cabell, L., and Audesirk, G. 2000. Inorganic lead and calcium
interact positively in activation of calmodulin. NeuroToxicology. 21, 353-263.

50

Kerper, L. E., and Hinkle, P. M. 1997. Cellular uptake of lead is activated by depletion of
intracellular calcium stores. J. Biol. Chem. 272, 8346-8352.
Kirchner, D. B. 2002. The spectrum of allergic disease in the chemical industry. Int.
Arch. Occup. Environ. Health. 75 Suppl, S107-112.
Klaassen, C. D. 1974. Biliary excretion of arsenic in rats, rabbits, and dogs. Toxicol.
Appl. Pharmacol. 29, 447-457.
Klaassen, C. D. 2001. Heavy metals and heavy-metal antagonists. In The
Pharmacological Basis of Therapeutics (J. G. Hardman, Limbird, L.E., and Gilman,
A.G., ed., pp. 1851-1875. McGraw-Hill, New York.
Kobla, H. V., and Volpe, S. L. 2000. Chromium, exercise, and body composition. Crit.
Rev. Food Sci. Nutr. 40, 291-308.
Kono, Y., Takahashi, M. A., and Asada, K. 1976. Oxidation of manganous
pyrophosphate by superoxide radicals and illuminated spinach chloroplasts. Arch.
Biochem. Biophys. 174, 454-462.
Kortenkamp, A., Ozolins, Z., Beyersmann, D., and O'Brien, P. 1989. Generation of PM2
DNA breaks in the course of reduction of chromium(VI) by glutathione. Mutat. Res.
216, 19-26.
Langård, S. 1982. Absorption, transport, and excretion of chromium in man and
animals. In Biological and Environmental Aspects of Chromium (S. Langård, ed.),
pp. 169-194. Elsevier/North-Holland Biomedical Press., Amsterdam.
Langård, S., and Norseth, T. 1979. Chromium. In Handbook on the Toxicology of
Metals. (L. Friberg, G. F. Nordberg and V. Vouk, eds.), pp. 383-397. Elsevier/NorthHolland Biomedical Press, Amsterdam.

51

Larsen, E. K., and Berg, T. 2001. Trace element speciation and international food
legislation - A Codex Alimentarius position paper on arsenic as a contaminant. In
Trace Element Speciation for Environment, Food and Health (L. Ebdon, L. Pitts, R.
Cornelis, H. Crews, O. F. X. Donard and P. Quevauviller, eds.), pp. 251-260. Royal
Society of Chemistry, Thomas Graham House, Science Park, Milton Road,
Cambridge.
Lee, J., Peña, M. M. O., Nose, Y., and Thiele, D. J. 2002. Biomedical characteristics of
the human copper transporter Ctr1. J. Biol. Chem. 277, 4380-4387.
Lindgren, A., Vahter, M., and Dencker, L. 1982. Autoradiographic studies on the
distribution of arsenic in mice and hamsters administered 74As-arsenite or -arsenate.
Acta Pharmacol. Toxicol. (Copenhagen). 51, 253-265.
Long, G. J., Rosen, J. F., and Schanne, F. A. 1994. Lead activation of protein kinase C
from rat brain. Determination of free calcium, lead, and zinc by 19F NMR. J. Biol.
Chem. 269, 834-837.
Lopez-Quintela, M. A., Knoche, W., and Veith, J. 1984. Kinetics and thermodynamics of
complex formation between aluminium (III) and citric acid in aqueous solution. J.
Chem. Soc. Faraday Trans. 80, 2313-2321.
Magos, L., Halbach, S., and Clarkson, T. W. 1978. Role of catalase in the oxidation of
mercury vapor. Biochem. Pharmacol. 27, 1373-1377.
Mangels, A. R., Moser-Veillon, P. B., Patterson, K. Y., and Veillon, C. 1990. Selenium
utilization during human lactation by use of stable-isotope tracers. Am. J. Clin. Nutr.
52, 621-627.

52

Marafante, E., Rade, J., Sabbioni, E., Bertolero, F., and Foa, V. 1981. Intracellular
interaction and metabolic fate of arsenite in the rabbit. Clin. Toxicol. 18, 1335-1341.
Marafante, E., Vahter, M., and Dencker, L. 1984. Metabolism of arsenocholine in mice,
rats and rabbits. Sci. Total Environ. 34, 223-240.
Markovac, J., and Goldstein, G. W. 1988. Picomolar concentrations of lead stimulate
brain protein kinase C. Nature. 334, 71-73.
Mazaev, V. T., Tikhonova, Z. I., and Shlepnina, T. G. 1976. Distribution and elimination
of tin taken up into the organism in the form of organo-tin compounds. J. Hyg.
Epidemiol. Microbiol. Immunol. 20, 392-395.
McConnell, K. P., and Cho, G. J. 1965. Transmucosal movement of selenium. Am. J.
Physiol. 208, 1191-1195.
McConnell, K. P., and Hoffman, J. L. 1972. Methionine-selenomethionine parallels in E.
coli polypeptide chain initiation and synthesis. Proc. Soc. Exp. Biol. Med. 140, 638641.
McConnell, K. P., and Portman, O. W. 1952. Toxicity of dimethyl selenide in the rat and
mouse. Proc. Soc. Exp. Biol. Med. 79, 230-231.
Medinsky, M. A., Benson, J. M., and Hobbs, C. H. 1987. Lung clearance and disposition
of 63Ni in F344/N rats after intratracheal instillation of nickel sulfate solutions.
Environ. Res. 43, 168-178.
Medinsky, M. A., Cuddihy, R. G., Griffith, W. C., and McClellan, R. O. 1981a. A
simulation model describing the metabolism of inhaled and ingested selenium
compounds. Toxicol. Appl. Pharmacol. 59, 54-63.

53

Medinsky, M. A., Cuddihy, R. G., and McClellan, R. O. 1981b. Systemic absorption of
selenious acid and elemental selenium aerosols in rats. J. Toxicol. Environ. Health.
8, 917-928.
Mertz, W. 1969. Chromium occurrence and function in biological systems. Physiol. Rev.
49, 163-239.
Mertz, W. 1995. Risk assessment of essential trace elements: new approaches to
setting recommended dietary allowances and safety limits. Nutr. Rev. 53, 179-185.
Miettinen, J. K. 1973. Absorption and elimination of dietary mercury (Hg2+) and
methylmercury in man. In Mercury, Mercurials and Mercaptans (M. W. Miller and T.
W. Clarkson, eds.), pp. 233-243. Charles C. Thomas, Springfield.
Mills, K. C., and Curry, S. C. 1994. Acute iron poisoning. Emerg. Med. Clin. North Am.
12, 397-413.
Moesgaard, S., and Morrill, R. 2001. The need for speciation to realize the potential of
selenium in disease prevention. In Trace Element Speciation for Environment, Food
and Health (L. Ebdon, L. Pitts, R. Cornelis, H. Crews, O. F. X. Donard and P.
Quevauviller, eds.), pp. 261-284. Royal Society of Chemistry, Thomas Graham
House, Science Park, Milton Road, Cambridge.
Moore, W., Jr., Malanchuk, M., Crocker, W., Hysell, D., Cohen, A., and Stara, J. F.
1975. Whole body retention in rats of different 191Pt compounds following inhalation
exposure. Environ. Health. Perspect. 12, 35-39.
Morel, F. M. M. 1983. Complexaton: Trace Metals and Microorganisms. Principles of
Aquatic Chemistry. 301 pages, Wiley-Interscience, New York.

54

Morgareidge, K. 1963. Inorganic vs Organic As Metabolism. Food and Drug Research
Labs, Inc., Maspeth, NY.
Morin, M., Nenot, J. C., and Lafuma, J. 1972. Metabolic and therapeutic study following
administration to rats of 238Pu nitrate - A comparison with 239Pu. Health Phys. 23,
475-480.
Mroz, M., Balkissoon, R., and Newman, L. 2001. Beryllium. In Patty's Toxicology (E.
Bingham, B. Cohrssen and C. Powell, eds.), Vol. 2, pp. 177-220. John Wiley and
Sons, Inc., New York.
Munro, I. C. 1976. Naturally occurring toxicants in foods and their significance. Clin.
Toxicol. 9, 647-663.
Nieboer, E., Fletcher, G. G., and Thomassen, Y. 1999. Relevance of reactivity
determinants to exposure assessment and biological monitoring of the elements. J.
Environ. Monit. 1, 1-14.
Nieboer, E., and Richardson, D. H. S. 1980. The replacement of the nondescript term
heavy metals by a biologically and chemically significant classification of metal ions.
Environ. Pollut. Ser. B. 1, 3-26.
Niyogi, S., and Wood, C. 2003. Effects of chronic waterborne and dietary metal
exposures on gill metal-binding: Implications for the biotic ligand model. Human
Ecol. Risk Assess. 9, 813-846.
Nordberg, G., and Skerfving, S. 1972. Metabolism. In Mercury in the Environment. An
Epidemiological and Toxicological Appraisal (L. Friberg and J. Vostal, eds.), pp. 2991. CRC Press, Cleveland, OH.

55

Nordberg, M., Duffas, J., and Templeton, D. 2004. Glossary of terms used in
toxicokinetics (IUPAC recommendations 2003). Pure Appl. Chem. 76, 1033-1082.
Norseth, T., Alexander, J., Aaseth, J., and Langård, S. 1982. Biliary excretion of
chromium in the rat: a role of glutathione. Acta Pharmacol. Toxicol. (Copenhagen).
51, 450-455.
Oberdörster, G., Ferin, J., and Lehnert, B. E. 1994. Correlation between particle size, in
vivo particle persistence, and lung injury. Environ. Health Perspect. 102 Suppl 5,
173-179.
O'Brien, T. J., Ceryak, S., and Patierno, S. R. 2003. Complexities of chromium
carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutat.
Res. 533, 3-36.
O'Flaherty, E. J. 1996. A physiologically based model of chromium kinetics in the rat.
Toxico.l Appl. Pharmacol. 138, 54-64.
Olin, S. S. 1998. Between a rock and a hard place: methods for setting dietary
allowances and exposure limits for essential minerals. J. Nutr. 128, 364S-367S.
Otto, G. F., and Maren, T. H. 1950. Studies of chemotherapy of filariasis. Part V.
Studies on the pharmacology of arsenamide and related arsenicals. Am. J. Hyg. 51,
353-395.
Overby, L., and Frost, D. 1962. Nonavailability to the rat of the arsenic in tissues of
swine fed arsanilic acid. Toxicol. Appl. Pharmacol. 4, 38-43.
Paquin, P. R., Gorsuch, J. W., Apte, S., Batley, G. E., Bowles, K. C., Campbell, P. G.,
Delos, C. G., Di Toro, D. M., Dwyer, R. L., Galvez, F., Gensemer, R. W., Goss, G.
G., Hostrand, C., Janssen, C. R., McGeer, J. C., Naddy, R. B., Playle, R. C.,

56

Santore, R. C., Schneider, U., Stubblefield, W. A., Wood, C. M., and Wu, K. B. 2002.
The biotic ligand model: a historical overview. Comp. Biochem. Physiol. C Toxicol.
Pharmacol. 133, 3-35.
Parent, L., Twiss, M. R., and Campbell, P. G. C. 1996. Influences of natural dissolved
organic matter on the interaction of aluminum with the microalga chlorella: A test of
the free-ion model of trace metal toxicity. Environ. Sci. Technol. 30, 1713-1720.
Park, J. B., Bair, W., and Busch, R. 1972. Progress in beagle dog studies with
transuranium elements at Batelle-Northwest. Health Phys. 22, 803-810.
Paustenbach, D. J., Finley, B. L., Mowat, F. S., and Kerger, B. D. 2003. Human health
risk and exposure assessment of chromium (VI) in tap water. J. Toxicol. Environ.
Health A. 66, 1295-1339.
Petrilli, F. L., Rossi, G. A., Camoirano, A., Romano, M., Serra, D., Bennicelli, C., De
Flora, A., and De Flora, S. 1986. Metabolic reduction of chromium by alveolar
macrophages and its relationship to cigarette smoke. J. Clin. Invest. 77, 1917-1924.
Philpott, C. C. 2002. Molecular aspects of iron absorption: Insights into the role of HFE
in hemochromatosis. Hepatology. 35, 993-1001.
Picard, V., Govoni, G., Jabado, N., and Gros, P. 2000. Nramp 2 (DCT1/DMT1)
expressed at the plasma membrane transports iron and other divalent cations into a
calcein-accessible cytoplasmic pool. J. Biol. Chem. 275, 35738-35745.
Plankey, B. J., and Patterson, H. H. 1987. Kinetics of aluminum-fulvic acid complexation
in acidic waters. Environ. Sci. Technol. 21, 595-601.
POISINDEX® System. L. L. Toll and K. M. Hurlbut, eds,. MICROMEDEX, Greenwood
Village, Colorado.

57

Pomroy, C., Charbonneau, S. M., McCullough, R. S., and Tam, G. K. 1980. Human
retention studies with 74As. Toxicol. Appl. Pharmacol. 53, 550-556.
Pott, E., Henry, P., Ammerman, C., Merritt, A., Madison, J., and Miles, R. 1994. Relative
bioavailability of copper in a copper-lysine complex for chicks and lambs. Anim.
Feed Sci. Technol. 45, 193-201.
Proctor, D. M., Otani, J. M., Finley, B. L., Paustenbach, D. J., Bland, J. A., Speizer, N.,
and Sargent, E. V. 2002. Is hexavalent chromium carcinogenic via ingestion? A
weight-of-evidence review. J. Toxicol. Environ. Health A. 65, 701-746.
Rahola, T., Hattula, T., Korolainen, A., and Miettinen, J. K. 1973. Elimination of free and
protein-bound ionic mercury (203Hg2+) in man. Ann. Clin. Res. 5, 214-219.
Reaney, S. H., Kwik-Uribe, C. L., and Smith, D. R. 2002. Manganese oxidation state
and its implications for toxicity. Chem. Res. Toxicol. 15, 1119-1126.
Reiber, S., Kukull, W., and Standish-Lee, P. 1995. Drinking water aluminum and
bioavailability. J. Am. Water Works Assoc. 87, 86-100.
Rhoads, K., and Sanders, C. L. 1985. Lung clearance, translocation, and acute toxicity
of arsenic, beryllium, cadmium, cobalt, lead, selenium, vanadium, and ytterbium
oxides following deposition in rat lung. Environ. Res. 36, 359-378.
Roskams, A. J., and Connor, J. R. 1990. Aluminum access to the brain: a role for
transferrin and its receptor. Proc. Natl. Acad. Sci. U. S. A. 87, 9024-9027.
Rowbotham, A. L., Levy, L. S., and Shuker, L. K. 2000. Chromium in the environment:
an evaluation of exposure of the UK general population and possible adverse health
effects. J. Toxicol. Environ. Health B Crit. Rev. 3, 145-178.

58

Rusch, G. M., O'Grodnick, J. S., and Rinehart, W. E. 1986. Acute inhalation study in the
rat of comparative uptake, distribution and excretion for different cadmium containing
materials. Am. Ind. Hyg. Assoc. J. 47, 754-763.
Rydzynski, K. 2001. Vanadium, niobium, and tantalum. In Patty's toxicology (E.
Bingham, B. Cohrssen and C. H. Powell, eds.), Vol. 3, pp. 1-74. John WIley & Sons,
Inc., New York.
Schkroeder, H. A., Balassa, J. J., and Tipton, I. H. 1963. Abnormal trace metals in man:
titanium. J. Chronic Dis. 16, 55-69.
Schlesinger, R. B. (1995). Deposition and clearance of inhaled particles. In Concepts of
Inhalation Technology (R. O. McClelland and R. F. Henderson, eds.), pp. 191-224.
Taylor and Francis, Washington, D.C.
Sekaly, A. L. R., Mandal, R., Hassan, N. M., Murimboh, J., Chakrabarti, C. L., Back, M.
H., Grégoire, D. C., and Schroeder, W. H. 1999. Effect of metal/fulvic acid mole
ratios on the binding of Ni(II), Pn(II), Cu(II), Cd(II), and Al(III) by two wellcharacterized fulvic acids in aqueous model solutions. Anal. Chim. Acta. 402, 211221.
Shao, Z., and Suszkiw, J. B. 1991. Ca2+ -surrogate action of Pb2+ on acetylcholine
release from rat brain synaptosomes. J. Neurochem. 56, 568-574.
Simons, T. J. 1986. The role of anion transport in the passive movement of lead across
the human red cell membrane. J. Physiol. (Lond). 378, 287-312.
Sin, Y. M., Lim, Y. F., and Wong, M. K. 1983. Uptake and distribution of mercury in mice
from ingesting soluble and insoluble mercury compounds. Bull. Environ. Contam.
Toxicol. 31, 605-612.

59

Sin, Y. M., Teh, W. F., Wong, M. K., and Reddy, P. K. 1990. Effect of mercury on
glutathione and thyroid hormones. Bull. Environ. Contam. Toxicol. 44, 616-622.
Singh, J., Carlisle, D. L., Pritchard, D. E., and Patierno, S. R. 1998. Chromium-induced
genotoxicity and apoptosis: relationship to chromium carcinogenesis (review). Oncol.
Rep. 5, 1307-1318.
Smith, I., and Carson, B. 1977. Silver. National Institute of Environmental Health
Sciences, Research Triangle Park, NC.
Smith, R. P. 1992. A Primer of Environmental Toxicology. Lea and Fibiger, Philadelphia.
Sollman, T., and Schreiber, N. E. 1936. Chemical studies of acute poisoning from
mercury bichloride. Arch. Intern. Med. 57, 46-62.
Squibb, K. S., and Fowler, B. A. 1984. Intracellular metabolism and effects of circulating
cadmium-metallothionein in the kidney. Environ. Health Perspect. 54, 31-35.
Squibb, K. S., Pritchard, J. B., and Fowler, B. A. 1984. Cadmium-metallothionein
nephropathy: relationships between ultrastructural/biochemical alterations and
intracellular cadmium binding. J. Pharmacol. Exp. Ther. 229, 311-321.
Sternberg, J., and Imbach, A. 1967. Metabolic studies with seleniated compounds. II.
Turnover studies with Se75-methionine in rats. Int. J. Appl. Radiat. Isotopes. 18, 557568.
Stokinger, H. E. 1981. The metals. In Patty's Industrial Hygiene and Toxicology (G. D.
Clayton and F. E. Clayton, eds.), Vol. 2A Toxicology, pp. 1493-2060. John Wiley &
Sons, New York.
Stoner, H. B., Barnes, J. M., and Duff, J. I. 1955. Studies on the toxicity of alkyl tin
compounds. Br. J. Pharmacol. 10, 16-25.

60

Sunderman, F. W., Jr. 2001. Nasal toxicity, carcinogenicity, and olfactory uptake of
metals. Ann. Clin. Lab. Sci. 31, 3-24.
Sunderman, F. W., Jr., and Selin, C. E. 1968. The metabolism of nickel-63 carbonyl.
Toxicol. Appl. Pharmacol. 12, 207-218.
Suszkiw, J., Toth, G., Murawsky, M., and Cooper, G. P. 1984. Effects of Pb2+ and Cd2+
on acetylcholine release and Ca2+ movements in synaptosomes and subcellular
fractions from rat brain and Torpedo electric organ. Brain Res. 323, 31-46.
Suzuki, S., Itoh, M., and Ohmichi, M. 1998. Selective uptake of selenite by red blood
cells. Analyst. 123, 63-67.
Suzuki, T. 1969. Neurological symptoms from concentration of mercury in the brain. In
Chemical Fallout (M. W. Miller and G. G. Berg, eds.), pp. 245-257. Charles C.
Thomas, Springfield.
Swensson, A. 1952. Investigations on the toxicity of some organic mercury compounds
which are used as seed disinfectants. Acta Med. Scand. 143, 365-383.
Swietlik, R. 1998. Meaning of the term "speciation" in environmental chemistry.
Wiadomosci Chemiczne. 52, 587-595.
Takagi, Y., Okada, A., Sando, K., Wasa, M., Yoshida, H., and Hirabuki, N. 2002.
Evaluation of indexes of in vivo manganese status and the optimal intravenous dose
for adult patients undergoing home parenteral nutrition. Am. J. Clin. Nutr. 75, 112118.
Tallkvist, J., Bowlus, C. L., and Lönnerdal, B. 2000. Functional and molecular responses
of human intestinal Caco-2 cells to iron treatment. Am. J. Clin. Nutr. 72, 770-775.

61

Tam, G. K., Charbonneau, S. M., Bryce, F., and Sandi, E. 1982. Excretion of a single
oral dose of fish arsenic in man. Bull. Environ. Contam. Toxicol. 28, 669-673.
Taylor, A. 1996. Biochemistry of tellurium. Biol. Trace Elem. Res. 55, 231-239.
Taylor, D. M. 1962. The absorption of cobalt from the gastrointestinal tract of the rat.
Phys. Med. Biol. 6, 445-451.
Teaf, C. M., Tuovila, B. J., Zillioux, E. J., Shipp, A., Lawrence, G., and van Landingham,
C. 2004. Nickel carcinogenicity in relation to the health risks from residual oil fly ash.
Human Ecol. Risk Assess. 10, 665-682.
Templeton, D. M. 1999. Biomedical aspects of trace element speciation. Fresenius J.
Anal. Chem. 363, 505-511.
Templeton, D. M., Ariese, F., Cornelis, R., Danielsson, L. G., Muntau, H., Van Leeuwen,
H. P., and Lobinski, R. 2000. Guidelines for terms related to chemical speciation and
fractionation of elements. Definitions, structural aspects, and methodological
approaches. Pure Appl. Chem. 72, 1453-1470.
Thomson, C. D., Stewart, R. D., and Robinson, M. F. 1975. Metabolic studies in rats of
[75Se]selenomethionine and of 75-Se incorporated in vivo into rabbit kidney. Br. J.
Nutr. 33, 45-54.
Uthus, E. O., and Seaborn, C. D. 1996. Deliberations and evaluations of the
approaches, endpoints and paradigms for dietary recommendations of the other
trace elements. J. Nutr. 126, 2452S-2459S.
Vahter, M., Akesson, A., Lind, B., Bjors, U., Schutz, A., and Berglund, M. 2000.
Longitudinal study of methylmercury and inorganic mercury in blood and urine of

62

pregnant and lactating women, as well as in umbilical cord blood. Environ. Res. 84,
186-194.
Vahter, M., and Marafante, E. 1983. Intracellular interaction and metabolic fate of
arsenite and arsenate in mice and rabbits. Chem. Biol. Interact. 47, 29-44.
Vahter, M., and Norin, H. 1980. Metabolism of 74As-labeled trivalent and pentavalent
inorganic arsenic in mice. Environ. Res. 21, 446-457.
Van Landeghem, G. F., De Broe, M. E., and D'Haese, P. C. 1998. Al and Si: Their
speciation, distribution, and toxicity. Clin. Biochem. 31, 385-397.
Verity, M. A. 1995. Nervous system. In Metal Toxicity (R. Goyer, C. D. Klaassen, D.
Curtis and M. R. Waalkes, eds.), pp. 199-235. Academic Press, San Diego.
Vitarella, D., Wong, B. A., Moss, O. R., and Dorman, D. C. 2000. Pharmacokinetics of
inhaled manganese phosphate in male Sprague-Dawley rats following subacute (14day) exposure. Toxicol. Appl. Pharmacol. 163, 279-285.
Wapnir, R. A., and Stiel, L. 1986. Zinc intestinal absorption in rats: specificity of amino
acids as ligands. J. Nutr. 116, 2171-2179.
WHO (World Health Organization). 1973. Trace Elements in Human Nutrition:
Manganese. Report of a WHO Expert Committee. Technical Report Service, 532,
WHO, Geneva, Switzerland. p. 34-36.
WHO (World Health Organization). 1990. Methylmercury. Environmental Health Criteria,
144 pages, Geneva.
WHO (World Health Organization). 1991. Inorganic Mercury. Environmental Health
Criteria, 118 pages, Geneva.

63

WHO (World Health Organization), in collaboration with the Food and Agriculture
Organization of the United Nations and the International Atomic Energy Agency.
1996. Trace Elements in Human Nutrition and Health. World Health Organization,
Geneva.
Wiegand, H. J., Ottenwalder, H., and Bolt, H. M. 1985. Fast uptake kinetics in vitro of
51Cr

(VI) by red blood cells of man and rat. Arch. Toxicol. 57, 31-34.

Wilhelm, M., Jäger, D. E., and Ohnesorge, F. K. 1990. Aluminium toxicokinetics.
Pharmacol. Toxicol. 66, 4-9.
Williams, P. R., and Paustenbach, D. J. 2002. Risk characterization: principles and
practice. J. Toxicol. Environ. Health B Crit. Rev. 5, 337-406.
Windisch, W. 2002. Interaction of chemical species with biological regulation of the
metabolism of essential trace elements. Anal. Bioanal. Chem. 372, 421-425.
Winship, K. A. 1988. Toxicity of tin and its compounds. Adverse Drug React. Acute
Poisoning Rev. 7, 19-38.
Yeoh, T. S., Lee, A. S., and Lee, H. S. 1986. Absorption of mercuric sulphide following
oral administration in mice. Toxicology. 41, 107-111.
Yokel, R. A. 2001. Aluminum toxicokinetics at the blood-brain barrier. In Aluminium and
Alzheimer's Disease (C. Exley, ed.), pp. 233-260. Elsevier, New York.
Yokel, R. A., Crossgrove, J. S., and Bukaveckas, B. L. 2003. Manganese distribution
across the blood-brain barrier II. Manganese efflux from the brain does not appear to
be carrier mediated. NeuroToxicology. 24, 15-22.
Yuann, J. M., Liu, K. J., Hamilton, J. W., and Wetterhahn, K. E. 1999. In vivo effects of
ascorbate and glutathione on the uptake of chromium, formation of chromium(V),

64

chromium-DNA binding and 8-hydroxy-2'-deoxyguanosine in liver and kidney of
Osteogenic Disorder Shionogi rats following treatment with chromium(VI).
Carcinogenesis. 20, 1267-1275.
Zhong, W., Zhang, Q., Yan, Y., Yue, S., Zhang, B., and Tang, W. 1997. Reaction of a
platinum(IV) complex with native Cd, Zn-metallothionein in vitro. J. Inorg. Biochem.
66, 179-185.
Zhou, B., and Gitschier, J. 1997. hCTR1: a human gene for copper uptake identified by
complementation in yeast. Proc. Natl. Acad. Sci. U S A. 94, 7481-7486.

65

Figure 1. An example page from the toxicokinetics database.
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Figure 2. Pathways involved in Cr metabolism in erythrocytes (bottom) and formation of
DNA lesions by Cr(VI) (top). Cr(III) is poorly absorbed by cells while Cr(VI) is brought
into the cell via sulfate anion channels. Once in the cell Cr(VI) is reduced to Cr(III) –
a mutagenic form of Cr (adapted from O’Brien et al., 2003).
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Figure 3. Relationship between ionic and covalent indices for the metal and metalloid
ions. The covalent index has been divided into three classifications, Class A (oxygen
seeking; bottom), intermediate (center) and Class B (sulfur and nitrogen seeking;
top). From (Nieboer et al., 1999). Reproduced with permission.
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Table 1. Examples of the influence of valence on the clearance of metals.
Metal in valence state in left column cleared
more rapidly than in valence state in next
column
V(V)
V(IV)
vanadyl sulfate V(IV)

Cleared

Reference

From lung

(Edel and
Sabbioni, 1988)
(Hamel and
Duckworth, 1995)
(Norseth et al.,
1982)

Cr(IV)

sodium orthovanadate
V(V)
Cr(III)

From
tissues
Into bile

Cr(III)

Cr(IV)

Mn(II)α2-macroglobulin

Mn(III) transferrin

As(V)

As(III)

From
mammal,
due to
less cell
entry of
Cr(III)
From
mammal
Into urine

(Na3AsO3) As(III)

(Na2HAsO4) (As(V)

Into bile

As(V)

As(III)

Sb(V)

Sb(III)

From
organs
From
mammals,
including
humans

Sb(V)

Sb(III)

Into urine

Sb(III)

Sb(V)

Into feces

U(VI)

U(IV)

Excretion
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(Gibbons et al,
1976)
(Hogan and
Eagle, 1944)
(Cikrt and Bencko,
1974)
(Cikrt and Bencko,
1974)
(Boyd and Roy,
1929; Goodwin
and Page, 1943;
Abdallah and Saif,
1962)
(Gellhorn et al.,
1946; Edel et al.,
1983)
(Otto and Maren,
1950; Edel et al.,
1983)
(Stokinger, 1981),
p. 2005

Table 2. Toxicity of multiple valence metals as a function of the valence state.
LESS TOXIC
MORE TOXIC
LESS TOXIC
REFERENCES
VALENCE
VALENCE
VALENCE
As(III)
As(V)
(Hughes, 2002;
Aposhian et al., 2003)
Cr(III) < Cr(VI)

Cr(IV), Cr(V)
intermediates

Cr(III) < Cr(VI)

(Kasprzak, 1991;
Templeton et al., 2000)

Hg(I)

Hg(II)

Mn(II)

Mn(III)

Mn(IV)

(Chen et al., 2001;
Reaney et al., 2002)

Te(II)

Te(IV)

Te(VI)

(Goyer and Clarkson,
2001)

U(IV)

U(VI)

(Klaassen, 2001)
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